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Single Molecule Visualization of the DEAH-box ATPase Prp22 
Interacting with the Spliceosome 
 
By Eric Gunnar Anderson 
 
In eukaryotes, the spliceosome is a macromolecular ribonucleoprotein machine 
that excises introns from pre-mRNAs through two sequential transesterification 
reactions.  The chemistry and fidelity of pre-mRNA splicing are dependent upon a 
series of spliceosomal rearrangements, which are mediated by trans-acting 
splicing factors.  One key class of these factors is the DEAH-box ATPase subfamily 
of proteins, whose members couple ATP hydrolysis to promote RNP structural 
rearrangements within the spliceosome.  This is typified by Prp22, which promotes 
release of the spliced mRNA from the spliceosome and ensures fidelity of the 
second step of splicing.  This role is well documented through classical 
biochemical and yeast genetics methods.  Yet very little is known regarding the 
comings and goings of Prp22 relative to the spliceosome.  My thesis research 
investigated the dynamics of Prp22 during splicing by using single-molecule 
fluorescence methods that allowed direct observation of these events.  To do this, 
I helped construct a toolkit that combined yeast genetics, chemical biology and 
Colocalization Single Molecule Spectroscopy (CoSMoS) with in vitro splicing 
assays.  Specifically, my thesis research consisted of CoSMoS splicing 
experiments in which fluorescently labeled pre-mRNA, spliceosome components 
and Prp22 were directly visualized and analyzed.  Using these methods, I found 
that Prp22’s interactions with the spliceosome are highly dynamic and reversible.  
By simultaneously monitoring Prp22 and individual spliceosome subcomplexes, I 
was able to frame these Prp22 binding events in context relative to specific steps 
in spliceosome assembly and splicing.  These experiments provide insight into how 
Prp22 promotes mRNA release from the spliceosome and maintains splicing 
fidelity. 
  v 
TABLE OF CONTENTS 
 
Acknowledgements .............................................................................................. iii 
Abstract ................................................................................................................iv 
Table of Contents ................................................................................................. v 
List of Figures ...................................................................................................... vii 
Preface .................................................................................................................ix 
1  Introduction .................................................................................................... 1 
1.1  Splicing of precursor messenger RNAs by the spliceosome ................... 1 
1.2  The Chemistry of pre-mRNA Splicing ...................................................... 4 
1.3  The Spliceosome Assembly Cycle .......................................................... 6 
1.4  DExD/H-Box Proteins Involved in Splicing .............................................. 9 
1.5  Single-Molecule Approach ..................................................................... 18 
2  Single Molecule Splicing Assays ................................................................. 29 
2.1  Introduction ............................................................................................ 30 
2.2  Materials ................................................................................................ 34 
2.2.1  Design of Fluorescently-labeled pre-mRNA Substrates ........ 34 
2.2.1.1 Ligation of a fluorescent biotin handle to a pre-mRNA .......... 39 
2.2.2  Generation of Yeast Extracts Containing Tagged Proteins ... 40 
2.2.2.1 Labeling of Spliceosome Proteins with Fluorophores in Whole 
Cell Extract ............................................................................ 46 
2.2.3  Design of Flow Chambers for TIRF Microscopy and Single 
Molecule Experiments ........................................................... 46 
2.2.3.1 Preparation of Flow Chambers for Objective TIRF 
 Microscopy ............................................................................ 50 
2.3  Methods ................................................................................................. 53 
2.3.1  Ligation of a fluorescent biotin handle to a pre-mRNA 
transcript ................................................................................ 53 
2.3.2  Labeling of SNAP Proteins in WCE ....................................... 57 
2.3.3  Flow chamber cleaning and assembly ................................... 63 
2.3.4  pre-mRNA Immobilization and Addition of WCE to the Flow 
Cell ........................................................................................ 67 
2.4  Notes ..................................................................................................... 73 
3  The Dynamics of Prp22 During Splicing ...................................................... 76 
3.1  Introduction ............................................................................................ 74 
  vi 
TABLE OF CONTENTS 
3.2  Results .................................................................................................. 78 
3.2.1  Preparation of fluorescently labeled Prp22 for CoSMoS 
experiments ........................................................................... 78 
3.2.2  Prp22 binding dynamics and stoichiometry ........................... 82 
3.2.3  Prp22 relative to spliceosome activation ............................... 85 
3.2.4  Prp22 and NTC binding relative to intron release ................ 100 
3.3  Discussion ........................................................................................... 110 
3.3.1  Preparation of fluorescently labeled Prp22 for CoSMoS 
experiments ......................................................................... 110 
3.3.2  Prp22 binding stoichiometry ................................................ 112 
3.3.3  Prp22 dynamics relative to NTC (spliceosome activation) ... 113 
3.3.4  Relative to intron release (splicing)...................................... 118 
3.4  Materials and Methods ........................................................................ 121 
3.4.1  Preparation of whole cell extracts ........................................ 121 
3.4.2  Preparation of fluorescent pre-mRNAs ................................ 121 
3.4.3  Construction of flow chambers ............................................ 121 
3.4.4  CoSMoS TIRF microscopy .................................................. 121 
3.4.5  Analysis of CoSMoS data .................................................... 122 
4  Final Summary and Conclusions ............................................................... 123 
4.1  Development of CoSMoS methods for studying splicing ..................... 123 
4.1.1  Future development of CoSMoS ......................................... 124 
4.2  The dynamics of Prp22 during splicing ................................................ 125 
4.2.1  Future CoSMoS experiments with Prp22 and other splicing 
ATPases .............................................................................. 128 
4.3  Final thoughts ...................................................................................... 131 
Bibliography ...................................................................................................... 132 
 
 
  vii 
LIST OF FIGURES 
 
Figure 1.1  The central dogma in eukaryotes ............................................ 2 
Figure 1.2  Chemical mechanism of pre-mRNA splicing ........................... 5 
Figure 1.3  Overview of the spliceosome assembly cycle ......................... 8 
Figure 1.4  DEAH-box proteins drive splicing forward ............................. 11 
Figure 1.5  Prp16 and Prp22 proofread the first and second steps of 
splicing .................................................................................. 15 
Figure 1.6  Direct visualization of splicing using SMF microscopy .......... 20 
Figure 1.7  smFRET reveals pre-mRNA conformational dynamics during 
splicing .................................................................................. 22 
Figure 1.8  Dynamic assembly of the spliceosomes ............................... 24 
Figure 1.9  CoSMoS reveals a novel branched spliceosome assembly 
pathway ................................................................................. 26 
Figure 1.10  smFRET-CoSMoS shows pre-mRNA conformational dynamics 
relative to spliceosome assembly ......................................... 27 
Figure 2.1  Schematic overview of a CoSMoS experiment ..................... 32 
Figure 2.2  Schemes for splinted ligation to prepare fluorescent, 
biotinylated pre-mRNAs ........................................................ 38 
Figure 2.3  Reaction scheme for SNAP-tag protein labeling ................... 45 
Figure 2.4  Denaturing polyacrylamide gel purification of the pre-mRNA-
biotin handle following ligation .............................................. 55 
Figure 2.5  SEC apparatus used to remove excess bG dye from SNAP-
labeled WCE ......................................................................... 62 
Figure 2.6  Results from SNAP labeling of the spliceosomal Prp16 protein 
in yeast WCE with bG-DY549 ............................................... 62 
Figure 2.7  Construction of flow chambers for CoSMoS experiments ..... 71 
Figure 3.1  Preparation of labeled whole cell yeast extracts to be used in 
CoSMoS splicing experiments .............................................. 80 
Figure 3.2  Only 1 Prp22 protein binds to the spliceosome at a time ...... 83 
Figure 3.3  Prp22 dynamic binding to the spliceosome is RNA and ATP 
dependent ............................................................................. 87 
Figure 3.4  NTC binding appearance tends to precede Prp22 appearance
 .............................................................................................. 90 
Figure 3.5  Ordering of disappearance of Prp22 and NTC events .......... 92 
Figure 3.6  Determining the difference in appearance and disappearance 
times for Prp22 and NTC overlapping events ....................... 96 
Figure 3.7  Detailed examination of the wait and dwell times of Prp22 
binding to the spliceosome .................................................... 98 
Figure 3.8  Framing Prp22 binding dynamics to spliceosome assembly 
and intron release ............................................................... 101 
Figure 3.9  Binding of Prp22 to RPS30A containing pre-mRNA 
spliceosomes is RNA specific and ATP dependent ............ 102 
Figure 3.10  Prp22 and NTC exhibit similar binding patterns for RP51A and 
RPS30A pre-mRNAs ........................................................... 105 
  viii 
LIST OF FIGURES 
Figure 3.11  Assessing the fate of the RPS30A intron ............................ 109 
Figure 4.1  Exploring the DEAH-box proteins using CoSMoS ............... 130 
  ix 
PREFACE 
 
Some work reported in this dissertation has been published elsewhere. 
Chapter 2 has been published previously as:  (Anderson and Hoskins, 2014)  
 
 
 
 
 
 
 
  1 
CHAPTER 1. INTRODUCTION  
 
1.1 Splicing of precursor messenger RNAs by the spliceosome 
The central dogma of gene expression consists of the transcribing 
information from genomic DNA into RNA copies that are translated into proteins.  
In eukaryotes, genes are in pieces separated by intervening non-coding regions 
called introns (Gilbert, 1978).  Introns are not translated into proteins per se, but 
are important for regulation of gene expression (Moore and Proudfoot, 2009).  
The RNAs generated from the transcription of genomic DNA consist of the 
coding regions or exons, which are interrupted by introns. These transcripts are 
called precursor to messenger RNAs (pre-mRNAs) and are subject to a series of 
processing events within the nucleus resulting in the production and export of 
messenger RNA molecules (mRNAs) to be translated into proteins by the 
ribosome (Figure 1.1).  Pre-mRNA splicing (referred herein as splicing) is one of 
the critical RNA processing events which consists of the removal of introns and 
joining of exons of an mRNA.  Eukaryotic splicing is catalyzed by a multi-
megadalton enzyme called the spliceosome (Brody and Abelson, 1985). 
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Figure 1.1:  The central dogma in eukaryotes:  A pre-mRNA is transcribed from 
genomic DNA and processed to an mRNA that is exported to the cytoplasm and 
translated by the ribosome into protein.  Central to this processing is pre-mRNA 
splicing: the removal of introns and splicing of exons from a pre-mRNA 
 
.  
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The spliceosome is one of many macromolecular machines involved in 
gene expression and its regulation.   These machines often consist of RNAs and 
proteins interacting together, forming ribonucleoprotein complexes (RNPs).  
RNPs are intimately involved in and in some cases couple the processes of RNA 
transcription, splicing, transport/export, translation and silencing (Wahl et al., 
2009).  Indeed, the mRNA transcript itself is an RNP whose protein composition 
dramatically changes with each RNA processing event.  These RNP machines 
are relatively large and can consist of hundreds of parts, which makes for 
challenging studies of their workings.  Of these, the spliceosome is perhaps the 
most complicated and dynamic RNP, consisting of 5 small nuclear RNA-protein 
complexes called snRNPs (U1, U2, U4, U5 and U6), an all protein complex (the 
NTC or NineTeenComplex) and hundreds of proteins.  Yet describing the 
spliceosome as vast machine belies its dynamic nature and invites comparison to 
another large and more stable RNP “-ome”: the ribosome.  From a certain point 
of view, the spliceosome is a really a series of isolatable, assembly pathway 
intermediates.  The question of why the spliceosome is so complex has been and 
continues to be intriguing and challenging to answer. 
The unique complexity of the spliceosome can be addressed by 
examining its function as a cellular machine.  Splicing plays a critical role in the 
broad range of evolutionary complexity of eukaryotes.  Splicing in the budding 
yeast Saccharomyces cerevisiae (henceforth referred to as yeast) has been 
minimized to only 3% of its genes.  These intron-containing genes have been 
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evolutionarily selected to serve essential roles in the life cycle of the yeast and 
require minimal mutation and regulated expression.  On the other end of the 
range, the rich genetic diversity of higher eukaryotes is in large part due to the 
spliceosome-catalyzed splicing of pre-mRNAs from genes containing tens to 
hundreds of introns of vastly different lengths.  By selecting different exon 
combinations, a single gene can encode many possible alternate mRNAs, which 
increases the functional repertoire of the cell.  This process is called alternative 
splicing and is quite prevalent, with recent estimates of >95% (Pan et al., 2008).  
Whether splicing a single intron in yeast or alternative splicing in humans, the 
core RNP parts of the spliceosome are highly conserved(Anderson and Hoskins, 
2014).  The conservation of spliceosome complexity is a tribute to its essential 
roles in maintaining the fidelity and regulation of gene expression. 
1.2 The Chemistry of pre-mRNA Splicing 
The spliceosome is the enzyme that mediates the removal of introns and 
joining of exons from pre-mRNAs. Introns vary considerably in length but contain 
the 3 sites used for the chemistry of splicing.  Introns are flanked by conserved 
sequence elements consisting of 5′ and 3′ splice sites (SS) and contain a branch 
point sequence (BP).  Figure 1.2A depicts a minimal pre-mRNA with the 5´SS, 
3´SS and BP sequences from yeast.  These yeast intron sequence elements are 
highly conserved, with 75% of introns having a GUAUGU 5′ SS, 95% with a 
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The first reaction consists of a nucleophilic attack of the phosphodiester 
bond at the 5′ splice site by the 2′ hydroxyl of the branch point adenosine.  This 
results in a free 5′-exon and a lariat-exon intermediate consisting of the branched 
intron and 3′-exon.  During the second step, the 3′ hydroxyl of the 5′ exon attacks 
the 3′ splice site, which joins the exons and liberates the lariat intron.  Note that 
recent work by the Soo Chen-Cheng group has demonstrated the reversibility of 
the chemical steps of splicing (lariat formation and exon joining) and later 
showed competition between a novel debranching reaction and the reverse of 
the first step (Tseng and Cheng, 2008, 2013).  These studies were done by 
changing the ionic environment (i.e., mono and divalent cations) within the 
catalytic core of the spliceosome.   
The mechanism for self-splicing group II introns is quite similar to that of 
spliceosome catalyzed splicing (Valadkhan, 2010).  This brings into question as 
to why did something as complex as the spliceosome evolve into an essential 
cellular machine?  Given the minimal nature of information contained within the 
splice sites and branch point sequences, the problem is one of recognition of the 
correct sites for proper splicing.  The spliceosome then is required for efficient 
and faithful splicing that is coupled to other processes of gene expression. 
1.3 The Spliceosome Assembly Cycle  
The prevailing view of the spliceosome is that it does not act as a 
preformed complex but rather assembles stepwise on the pre-mRNA substrate 
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(Burge et al., 1999; Chen and Moore, 2014).  The assembly cycle has been 
detailed in both yeast and mammalian systems using in vitro biochemical 
methods such as native gel electrophoresis, affinity chromatography and gradient 
centrifugation.  The key stages of splicing have been operationally defined by the 
presence and absence of the snRNPs, the presence of reaction intermediates 
and products, and by native gel electrophoresis migration behavior (Will and 
Lührmann, 2011) (Figure 1.3).  Under this model, the stages of assembly are 
precursors to the next one (Brow, 2002). 
The first stage of assembly involves the recognition of the 5′ and 3′ splice 
sites and branch point sequence (BPS), resulting in E (early) complex.  This 
initial step is ATP-independent, whereas all of the remaining stages are ATP-
dependent.  The U1 snRNP binds to the 5′ splice site while the branch point and 
pyrimidine tract are recognized by BBP (yeast) and U2AF complex (mammalian) 
respectively.  The prespliceosome or A complex follows with BPS binding by the 
U2 snRNP, displacing BBP.  The U4/U6*U5 tri-snRNP then binds to the 5′ splice 
site region, yielding B complex.  At this stage, the spliceosome is catalytically 
inactive; extensive remodeling is required for the first step of splicing.  This 
remodeling involves the binding of the NTC and loss of the U1 and U4 snRNPs, 
resulting in the activated spliceosome or B*complex.  C complex arises after the 
first catalytic step, followed by more spliceosomal rearrangements from which the 
second step proceeds.  Following completion of the second step, the spliced 
mRNA is released and the spliceosome is disassembled, allowing for reuse of its  
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Figure 1.3:  Overview of the spliceosome assembly cycle.  The spliceosome 
assembles step-wise on the pre-mRNA substrate forming a series of complexes.  
Emphasized is the dynamic nature of the spliceosome, with a branched pathway 
to A Complex, reversibility of all assembly steps and the splicing itself.  After 
release of the spliced mRNA, the spliceosome is disassembled and its 
components available for another round of splicing. 
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components for the splicing of other substrates.  The assembly stages and 
associated rearrangements listed above exemplify the dynamic nature of the 
spliceosome and provide a glimpse into how splicing is regulated.   
Although spliceosomal complexes are defined by their snRNP 
composition, proteins also play a critical role in splicing.  By shear mass, proteins 
are thought to account for more than two-thirds of the spliceosome (Jurica and 
Moore, 2003).  Mass spectrometry proteomics surveys have provided the parts 
list and highlighted the dynamic composition of the spliceosome (Fabrizio et al., 
2009).  Interestingly, the yeast spliceosome consists of ~90 proteins that are 
conserved within the ~300 spliceosomal proteins found in metazoans.  As core 
components of the snRNPs, splicing proteins are intricately involved in providing 
the framework for splicing to occur and may even be involved in catalysis 
(Abelson, 2008). 
1.4 DExD/H-Box Proteins Involved in Splicing  
In addition to the snRNP and NTC proteins, there are other trans-acting 
proteins that act as splicing factors.  This class of trans-factors is best typified by 
the SR proteins (serine/arginine-rich), which promote alternative splicing in 
metazoans and the DExH/D box proteins, whose actions as ATPases/helicases 
are required for remodeling of the spliceosome. 
DExD/H-box proteins are pervasive in RNA metabolism events, ranging 
from transcription, splicing, transport and translation (Silverman et al., 2003).  
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The DExD/H-box family is highly conserved and owe their name to the conserved 
sequence motif (Asp-Glu-Any-Asp/His).  They are perhaps best known for their 
ability to unwind RNA duplexes in an ATP-dependent manner (Anna Marie Pyle, 
2008). The helicase domain is responsible for the helicase and ATPase activity 
of these proteins.  This ATPase activity is RNA-dependent and is thought to 
power translocation of the DEAH-box sub-group along their substrate.  This 
helicase or unwindase activity has been demonstrated in vitro using generic 
nucleic acid duplexes and/or RNA-protein complexes (Jankowsky and Bowers, 
2006).   
DExH/D-box proteins are extensively involved in pre-mRNA splicing.  
These splicing trans-factors were first identified in a yeast genetic screen for 
splicing deficiencies (Lustig et al., 1986; Rosbash et al., 1981).  Nearly all 
transitions and steps in splicing are governed by a DExH/D-box protein (Figure 
1.4).  Prp2, along with its binding partner, Spp2, are required for catalytic 
activation of the spliceosome by displacing the U2 snRNP subcomplex SF3b 
complex from the branch point region (Lardelli et al., 2010; Roy et al., 1995).  
Prp16 and Prp22 are respectively involved in the transition between the first and 
second steps, and the second step and mRNA release from the spliceosome.  
Finally Prp43 is required for lariat-intron removal and spliceosome disassembly 
after splicing has occurred (Martin et al., 2002).  Not all splicing DExH/D-box 
proteins are external factors – the DEIH-box protein Brr2 is an integral part of the 
U5 snRNP and with the 
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GTPase Snu114 acts at temporally distinct stages during splicing (Maeder et al., 
2009).   
Prp16 is the most extensively studied of the spliceosomal DEAH-box 
proteins and was first identified in a yeast genetic screen for splicing deficient 
mutants (Couto et al., 1987).  Prp16p is a DEAH-box ATPase that is capable of 
unwinding RNA duplexes in vitro (Wang et al., 1998).  While its helicase domain 
is highly conserved within the DEAH-box protein family, its unique N-terminal 
domain is required for binding to the spliceosome (Wang and Guthrie, 1998).  
Interestingly, when expressed as separate domains, the N-terminal and helicase 
domains can act together (i.e. trans-complementation), recapitulating Prp16 
functionality both in vivo and in vitro. 
Prp16 acts during the transition between the first and second steps 
(Schwer and Guthrie, 1991).  It is thought to use its ATPase activity to remodel 
the spliceosome conformation such that the substrate (free 5′-exon and lariat-
intermediate) are positioned properly for the second transesterification reaction.  
How exactly it effects this change is not known, but recent evidence shows Prp16 
facilitates the removal of the protein Cwc25, which binds near the branch point 
after activation (Lardelli et al., 2010; Ohrt et al., 2013; Tseng et al., 2011).  As a 
trans-factor, Prp16’s interaction with the spliceosome is transient and is no longer 
associated with the spliceosome prior to completion of the second step (Schwer 
and Guthrie, 1991). 
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Prp22 is a DEAH-box protein that acts during second step and promotes 
release of the spliced mRNA from the spliceosome (Company et al., 1991).  Its 
function during the second step is ATP-independent and requires the ordered 
binding of the proteins Slu7 and Prp18 to the spliceosome (James et al., 2002).  
However, recent data from reconstitution and cross-correlation spectroscopy 
experiments from the Luhrmann lab shows only Slu7 and Prp18 but not Prp22 
are required for the second step (Ohrt et al., 2013).  Based on data from 
crosslinking and RNase H protection assays, Beate Schwer has proposed a 
model in which Prp22 facilitates mRNA release by binding downstream of the 3′-
exon after exon ligation (Schwer, 2008).  Prp22 then uses its ATPase activity to 
disrupt RNA-RNA and/or RNA-protein interactions between the mRNA and the 
spliceosome, perhaps the U5 components U5 snRNA-Loop I and Prp8 (Aronova 
et al., 2007). 
The crystal structure of Prp43 provides some insight into how these 
DEAH-box proteins might work when modeled after the Ski2-like helicases (He et 
al., 2010; Walbott et al., 2010).  Upon binding of the RNA substrate, the two recA 
domains form a pocket for ATP binding and hydrolysis.   ATP hydrolysis is 
thought to power a ratcheting mechanism in which the duplex RNA substrate is 
pulled into and through a β-sheet, leading to strand unwinding and translocation 
of the helicase.  Given the highly conserved nature of the DEAH-box proteins, it 
is tempting to ascribe a similar model to Prp2, Prp16, and Prp22. 
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The DEAH-box proteins Prp2, Prp16, Prp22 and Prp43 also act as kinetic 
proofreaders in maintaining splicing fidelity (Figure 1.5).  Kinetic proofreading 
was originally proposed as a model to account for fidelity of tRNA selection by 
the ribosome (Hopfield, 1974; Ninio, 1975).  This model holds that optimal 
substrates are favorably selected through kinetic discrimination.  That is, the 
selection process and catalysis are in competition with coupled ATP hydrolysis 
by in this case a DExD/H-box protein.  If a suboptimal substrate is present, its 
catalytic rate will be slower than that of the ATPase, and will thus be discarded.  
In the context of splicing, Prp2 ensures proper activation of spliceosomes 
(Wlodaver and Staley, 2014), Prp5 proofreads U2 snRNA basepairing to the 
branch point region (Xu and Query, 2007), Prp16 maintains fidelity of BP 
recognition (Burgess and Guthrie, 1993; Koodathingal et al., 2010) while Prp22 
proofreads the fidelity of exon joining (Mayas et al., 2006).  Jon Staley’s group 
showed that Prp43 is not only involved in spliceosome disassembly post splicing, 
but also in a discard pathway when aberrant splicing is proofread by Prp16 or 
Prp22 (Mayas et al., 2010).  This couples with work from the Soo Chen-Cheng 
lab that claimed Prp43 access spliceosomes after rearrangements mediated by 
Prp2, Prp16 and Prp22 (Chen et al., 2012).  These observations are consistent 
with a model in which Prp43’s disassembly role is restricted to lariat intron 
spliceosomes if splicing is on pathway and fast relative to the activity of DEAH-
box proteins.  However, an off pathway splicing event with relatively slow kinetics 
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There remain several open questions concerning DEAH-box proteins and 
their roles as splicing proofreaders.  The nature of the discard step for suboptimal 
substrates has not been fully addressed.  Discard could entail repeated cycles of 
rejection and testing of substrates, or involve an irreversible spliceosome 
disassembly pathway.  The kinetic details of the transient interactions of DEAH-
box proteins with the spliceosome have not been determined.  In particular, it is 
not known how their remodeling actions are timed or specified to their associated 
splicing events.     
Given the dual roles as remodelers and proofreaders, each transition of 
splicing mediated by a DEAH-box protein is potentially a proofreading and/or 
remodeling event (see Figures 1.4 - 1.5).  These questions of discard, timing, 
and specificity become more pertinent when the number of DEAH-box proteins 
involved in splicing is considered.    Given the highly conserved nature of these 
proteins, one hypothesis is they share a common binding site within the 
spliceosome or are regulated commonly somehow at their correct time.  This 
would imply that their binding is mutually exclusive, which has not been 
demonstrated.  DEAH-box protein binding and therefore activity could be 
mediated by co-factors or even the conformation of the spliceosome itself (Smith 
et al., 2008).  Another hypothesis is the conformational rearrangements made by 
one helicase provides the substrate for another, thereby forming a cascade of 
rearrangements (Cordin et al., 2012).  Understanding the interactions of DEAH-
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box proteins with the spliceosome and the molecular rearrangements that ensue 
will help provide a mechanistic picture of splicing.   
Classical biochemical techniques have revealed a wealth of information 
concerning pre-mRNA splicing and spliceosome assembly.  These techniques 
include in vitro splicing assays, native gel electrophoresis, co-
immunoprecipitation, cross-linking and nuclease protection assays.  However, 
efforts to study the spliceosomal interactions of DEAH-box proteins using these 
biochemical tools have been hampered.  These techniques often require purified 
spliceosomes or stalling of splicing at key intermediate states to provide 
synchrony.  This stalling, be it from splicing inhibitors, mutant pre-mRNA 
substrates, or immunodepletion, is not always possible for all of the intermediate 
states.   
Historically these limitations led to the use of unfractionated whole-cell 
extracts (WCE) from mammalian or yeast cultures for biochemical studies of 
splicing (Lin et al., 1985). WCE contain all of the components required for 
assaying splicing in vitro and have provided the basis for the biochemical 
experiments used to elucidate the mechanisms involved in splicing.  However, 
the splicing components in a WCE are subject to dilution effects from the loss of 
nuclear compartmentalization and possible degradation from nucleases and 
proteases.  Until recently, the spliceosome has eluded the reach of classical 
biochemical techniques of using purified components to reconstitute splicing 
activity in vitro (Warkocki et al., 2009).  While an impressive feat, this is really a 
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semi-reconstituted system in that B-complex spliceosomes are first prepared and 
arrested in a splicing assay with WCE.  The arrested spliceosome can be forced 
along the forward pathway by adding the required trans-acting splicing proteins 
that are prepared recombinantly.  The Lührmann group has used this method to 
investigate the disassembly pathway post-splicing and to dissect the second step 
(Fourmann et al., 2013; Ohrt et al., 2013).   
1.5 Single-Molecule Approach 
In order to gain a fundamental understanding of the mechanism of 
spliceosome-mediated splicing, new tools are required.  Single-molecule 
methods first gained prevalence as a biophysical technique in the form of patch-
clamp and single ion channel recordings during the 1970’s (Neher and Sakmann, 
1976).  Since then, single-molecule techniques have grown to include atomic 
force microscopy, optical tweezers and single-molecule fluorescence 
microscopy.  Compared to ensemble-based studies, single-molecule studies 
provide very high sensitivity. This allows access to the underlying subpopulations 
and heterogeneity of complex systems.  In terms of enzyme kinetics, single-
molecule experiments can identify transient intermediates and multiple reaction 
pathways.  These observations are often obscured by the averaging associated 
with ensemble methods.  
Single-molecule studies have already provided a deeper understanding of 
the ribosome, motor proteins and RNA/protein folding (Blanchard et al., 2004; 
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Nettels et al., 2007; Yildiz et al., 2003; Zhuang et al., 2000).  What then, can 
single-molecule experiments tell us about splicing?  Spliceosome catalyzed 
splicing is a highly complex and dynamic process involving many transitions and 
structural rearrangements.  A single-molecule approach allows direct observation 
of splicing in real-time, including rare or transient interactions, without the need 
for synchronization.  Single-molecule fluorescence (SMF) microscopy is 
particularly well-suited in this regard, and should be viewed as a complement to 
biochemical ensemble methods. 
Pre-mRNA splicing is well suited for single molecule studies since the 
overall spliceosome assembly pathway and splicing reaction are known with an 
established in vitro assay.  However, SMF splicing TIRF experiments require 
fluorescently labeled pre-mRNAs and proteins, for which new labeling methods 
had to be empirically developed.  In particular, the model pre-mRNA had to be 
prepared piece-wise, site-specifically labeled with fluorophore(s), ligated together 
and derivatized with a biotin for attachment to the glass slide surface.  In order to 
avoid dye photobleaching, an oxygen scavenging system compatible with 
splicing was developed.  Early work by Aaron Hoskins and Danny Crawford 
demonstrated the feasibility of such an approach and for the first time visualized 
the ATP-dependent removal of a labeled intron (Crawford et al., 2008) (Figure 
1.6). 
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Figure 1.6:  Direct visualization of splicing using SMF microscopy.  (a) 
Experimental scheme in which a pre-mRNA labeled with dyes is attached to the 
slide surface and able to report splicing via loss of intron fluorescence.  (b-i) 
Time-lapsed TIRF images of wild-type and branch point mutant pre-mRNA 
showing loss of intron (yellow boxes).  (j) SMF traces of wild type pre-mRNAs 
during splicing.  (k)  Plot of intron signal survival for wild type (diamond) and 
branch point mutant (X) pre-mRNAs during a SMF splicing reaction.  Figure from 
(Crawford et al., 2008).    
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Using a similar approach, a collaboration between the Christine Guthrie 
and Nils Walter labs used a dual-labeled pre-mRNA for observing splicing 
dynamics by single molecule FRET (smFRET) (Abelson et al., 2010a).  By 
placing the FRET dye pair near the 5′ and 3′ splice sites, they found the pre-
mRNA adopted highly dynamic conformations under in vitro splicing conditions 
(Abelson et al., 2010b) (Figure 1.7a).  While intriguing, it is difficult to interpret 
the FRET dynamics without a reference to spliceosome assembly or splicing 
events.  To resolve this issue they followed up with a study using a smFRET pre-
mRNA in affinity-purified spliceosomes that were stalled before the activation 
step (Krishnan et al., 2013).  By adding recombinant proteins Prp2 and Spp2 with 
ATP they were able to observe the pre-mRNA dynamics associated with 
spliceosome activation.  Finally, they added fluorescently labeled Cwc25, a 
protein required for the first step, and observed FRET with the branch site 
presumably during the first step (Figure 1.7b). 
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Figure 1.7:  smFRET reveals pre-mRNA conformational dynamics during 
splicing.  A.  Scheme for using a SMF-TIRF microscope for observing FRET 
between the splice sites of a pre-mRNA tethered to the slide surface.  FRET is a 
measure of the dynamics of a pre-mRNA and can be monitored over time in 
different splicing conditions.  B.  Scheme for combining smFRET with labeled 
Cwc25 protein.  After bleaching the acceptor dye on the pre-mRNA, FRET can 
be observed between the protein and the pre-mRNA during splicing.  Figures 
adopted from  (Abelson et al., 2010b; Krishnan et al., 2013).  
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Pioneered by Jeff Gelles and Larry Friedman, the CoSMoS (Colocalization 
Single Molecule Spectroscopy) is a single molecule technique that uses TIRF 
microscopy to watch labeled biomolecules interact with a differently labeled 
molecule tethered to the slide surface (Friedman and Gelles, 2015; Friedman et 
al., 2006).  The Gelles lab has used this technique to study the kinetics of 
transcription initiation (Friedman and Gelles, 2012).   
Through a collaboration between the Moore and Gelles labs, CoSMoS has 
been used extensively to study splicing dynamics and spliceosome assembly.  In 
order to observe splicing protein dynamics relative to pre-mRNAs tethered to the 
slide surface, specific protein labeling strategies had to be developed.  These 
methods needed to be compatible with the whole cell extracts used in in vitro 
splicing assays.  After extensive trials and testing, we arrived at using an 
orthogonal combination of covalent (i.e. Snap-tag) and non-covalent (E. coli 
DHFR-trimethoprim) protein fluorescent labeling technologies (Keppler et al., 
2002; Miller et al., 2005) (see section 2.2.2). 
Armed with labeled pre-RNAs and spliceosomal proteins, Aaron Hoskins 
first used the CoSMoS technique to directly observe spliceosome assembly 
events (Hoskins et al., 2011).  He found spliceosome assembly in yeast is 
ordered and features reversible binding for all steps, with not one step being rate-
limiting.  Furthermore, all steps can lead to a discard pathway (Figure 1.8). 
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Inna Scherbakova followed this work by studying spliceosome assembly 
pathways for different yeast pre-mRNAs (Shcherbakova et al., 2013).  She found 
a branched pathway where either U1 or U2 can bind first to make functional A-
complex spliceosomes (Figure 1.9).  It is particularly interesting to note the 
possibility of different spliceosome assembly pathways associated with different 
pre-mRNAs, since a majority of in vitro splicing uses one model pre-mRNA (i.e., 
ACT1 intron).  This was also the first CoSMoS publication that introduced the use 
of a visual tool called rastergrams, which are able to convey the entirety of a 
single molecule experiment, in this case displaying the U1 and U2 binding events 
and the fate of the intron (see Figure 1.9D).   
Finally, Danny Crawford combined CoSMoS with smFRET to pair pre-
mRNA splicing dynamics with spliceosome assembly events (Crawford et al., 
2013) (Figure 1.10A).  Using a pre-mRNA labeled with a FRET dye pair at the 
branch point and 5′SS regions, he found that in buffer the pre-mRNA compacts, 
yielding a high FRET state.  Once WCE was introduced, the branch point and 
5′SS remain distal well into the spliceosome assembly cycle.  By using WCE with 
labeled NTC complex, he observed a shift in the FRET state after arrival of the 
NTC complex and activation of the spliceosome (Figure 1.10B).  This allows for 
more time for splice site selection later in the assembly pathway than previously 
appreciated. 
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Figure 1.9 CoSMoS reveals a novel branched spliceosome assembly pathway.  
A  Scheme for CoSMoS experiment using labeled U1 and U2 extract and a pre-
mRNA with a labeled intron for monitoring splicing.  B  Intron signal loss is in 
WCE is ATP dependent.  C  Intron signal traces showing loss due to splicing 
(top) or photobleaching (bottom).  D  Rastergram showing U1 (red), U2 (green) 
or both (yellow) binding to a pre-mRNA with a labeled intron.  The rastergram is 
sorted by the time of intron loss (gray shading).  G  Model for U1 or U2 branched 
assembly pathway – both can lead to productive spliceosomes.  Figures from 
(Shcherbakova et al., 2013)   
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This dissertation presents work previously published (Anderson and 
Hoskins, 2014) concerning the development of methods for constructing a 
CoSMoS splicing toolkit.  These methods, particularly the development and 
optimization of fluorescent labeling of specific proteins in WCE, were critical for 
the CoSMoS splicing experiments detailed above.  Finally, these methods were 
used to observe the dynamics of the Prp22 DEAH-box protein relative to 
spliceosome assembly and activation events and splicing itself. 
            29 
CHAPTER 2. SINGLE MOLECULE SPLICING ASSAYS 
  
 
 
Preface:  The work presented in this chapter is reproduced from previously 
published work (Anderson and Hoskins, 2014), of which Aaron Hoskins and I are 
co-authors.  I contributed by writing sections 2.2.1 and 2.2.2, preparing figures 
2.1, 2.2, 2.3, 2.4, and 2.5, helping with the final proofing, formatting and editing.  
This work is reproduced with permission from the publisher (Springer, License # 
3773310948905). 
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2.1  Introduction 
The application of single molecule techniques to analyze biochemical 
processes has become increasingly prevalent for elucidating complex reaction 
pathways and has been applied to a wide range of systems including replication, 
transcription, and translation (Dulin et al., 2013).  These methods often measure 
fluorescence light emitted from a dye-labeled biomolecule [e.g., single molecule 
colocalization or fluorescence resonance energy transfer (FRET) experiments] or 
the response of a biomolecule to force (e.g., optical traps, magnetic tweezers, or 
atomic force microscopy) (Dulin et al., 2013).  The ability to follow reaction 
trajectories of individual biomolecules is an extremely powerful approach for 
studying biochemical reactions, particularly when transient or low-abundance 
intermediates cannot be observed in bulk assays due to ensemble averaging 
(Weiss, 2000).  Additionally, the elaborate assembly pathways for 
macromolecular machines can be easily deconvoluted using single molecule 
fluorescence colocalization assays to follow construction of a single complex 
from start to finish (Friedman and Gelles, 2012; Joo et al., 2013; Tsai et al., 
2012).  
 Recently, single molecule approaches have begun to shed new light on 
the mechanisms of spliceosome assembly and the splicing of precursor mRNAs 
(pre-mRNAs) (Hoskins et al.)  Unlike most single molecule experiments that are 
carried out using highly purified components, single molecule splicing reactions 
to date have been carried out in yeast whole cell extract (WCE).  This has 
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presented a set of unique challenges at nearly each stage of the single molecule 
experiment—from fluorophore labeling in WCE to image acquisition to data 
analysis.  Despite the experimental complexity, single molecule methods have 
been used to study both pre-mRNA conformational changes during splicing 
(Abelson et al., 2010a) and the dynamic interactions of spliceosome 
subcomplexes [the U1 and U2 small nuclear ribonucleoproteins (snRNPs), the 
U4/U6.U5 tri-snRNP, and the Prp19-associated complex (NTC)] with pre-mRNA 
(Hoskins et al., 2011).  Both sets of experiments showed that a number of 
transitions along the splicing pathway appear readily reversible.  Analysis of 
spliceosome assembly reaction kinetics further revealed that steps in this 
process are highly ordered on the RP51A substrate and no single step appeared 
to limit the rate of the overall assembly reaction (Hoskins et al., 2011).    
The results described above concerning spliceosome assembly were 
obtained by CoSMoS—Colocalization Single Molecule Spectroscopy (Friedman 
et al., 2006; Hoskins et al., 2011).  In CoSMoS experiments of splicing, the pre-
mRNA is often attached to the surface and fluorescent spliceosome 
subcomplexes or splicing factors are monitored as they bind to and release from 
the pre-mRNA (Figure 2.1).  These proteins or subcomplexes are labeled with 
different colors of fluorophores such that each species can be individually tracked 
and distinguished from the tethered pre-mRNAs. 
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Figure 2.1  Schematic overview of a CoSMoS experiment.  (A) Drawing of a flow 
chamber with 4 lanes; the gray circle depicts an area imaged during an 
experiment (~400 µm2).  (B) Magnified portion of a field of view from a 2-color 
CoSMoS experiment.  The left square shows single molecules (spots) of pre-
mRNA labeled with a red fluorophore and fluorescence imaged at > 635 nm.  The 
right square shows the same field of view with single molecules of a SNAP-
labeled spliceosome protein bound to the surface-tethered pre-mRNA and 
imaged with a green fluorophore at < 635 nm.  (C) Drawing of a SNAP-labeled 
Prp16p molecule interacting with a surface tethered pre-mRNA. The pre-mRNA 
is attached to the slide through a biotin:streptavidin:biotin linkage. 
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CoSMoS experiments are enabled by both surface tethering of the pre-
mRNA and TIRF illumination.  The evanescent wave of energy that is used to 
excite fluorophores by TIRF dissipates rapidly from the glass/water interface.  
This means that only fluorophores within ~100nm of the surface become excited 
and emit light.  Additionally, molecules must remain fixed in position for a time 
period comparable with the camera frame rate to be observed in a CoSMoS 
experiment, thus, necessitating surface tethering of one of the fluorescent 
components for viewing discrete “spots” of single molecule fluorescence.  
Molecules that transiently pass through the evanescent field cannot be discerned 
as discrete “spots” but blur into the background since the camera frame rate in 
most microscopy experiments (maximum speed of ~500 fr/s) is much slower than 
diffusion.  Consequently, experiments can be performed with free, fluorescent 
molecules in solution at concentrations <100 nM.  The surface tethering is 
accomplished either by direct attachment of a biomolecule to a surface or 
indirectly by binding interactions between a fluorescent biomolecule in solution 
and its immobilized partner.  It is critical that the surface be sparsely populated 
with biomolecules to ensure that fluorescent spots of single molecules are being 
separately observed. 
Key to the implementation of a multi-color CoSMoS experiment is the 
efficient detection of photons emitted from different fluorophores excited by 
lasers of different wavelengths.  This can be accomplished using a TIRF 
microscope design pioneered by the Gelles laboratory called micromirror TIRF 
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(mmTIRF) (Friedman et al., 2006).  In mmTIRF, small broadband mirrors (mm in 
size) are used to direct the excitation laser light into and out of the microscope 
objective.  This leaves the center of the objective free for fluorescence emission 
and unobstructed by dichroic mirrors found in other designs.  Details on the 
construction of a mmTIRF microscope for CoSMoS as well as other TIRF 
microscope configurations have been published elsewhere (Friedman et al., 
2006; Selvin, 2008).  
In this chapter, we focus on the preparation of three components of a 
typical CoSMoS splicing assay: synthesis of a fluorescent and biotinylated pre-
mRNA, labeling of spliceosome proteins in a yeast whole cell extract (WCE) with 
the SNAP tag, and assembly of flow chambers for an objective-based TIRF 
microscope.  We then provide a protocol for putting these components together 
to perform a CoSMoS experiment between a surface tethered pre-mRNA and a 
single, SNAP-labeled spliceosome component.  Due to the diversity in 
microscope designs and software implementation, we do not focus in this chapter 
on the specifics of image acquisition and processing, as this will vary lab-to-lab.  
 
2.2 Materials 
2.2.1 Design of Fluorescently-labeled pre-mRNA Substrates 
In order to monitor spliceosome assembly and/or RNA splicing by 
CoSMoS, pre-mRNA substrates are immobilized on a streptavidin-coated glass 
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surface and their locations determined by fluorescence.  We typically construct 
two types of fluorescent pre-mRNAs for CoSMoS: location reporters and splicing 
reporters.  Location reporters contain a single fluorophore and biotin located near 
the 3' end of the pre-mRNA.  Splicing reporters contain fluorophores located in 
either the 5' or 3' exon or intron in addition to a biotin modification at the 3' end.  
The construction of splicing reporters has previously been described in detail 
(Abelson et al., 2010b; Crawford et al., 2008, 2013) and is beyond the scope of 
this article.  We will instead focus on the more straightforward construction of 
location reporters.  We have found that the most versatile approach is to 
incorporate a fluorophore and biotin into a short oligonucleotide (oligo) or 
“handle” that is ligated to the pre-mRNA 3' end in a single step rather than direct 
modification of the RNA transcript.  This approach allows a great deal of flexibility 
in the choice of fluorophore and pre-mRNA substrate. 
Similar to ensemble experiments, relatively few pre-mRNA substrates 
have been used in single-molecule studies.  For studying the yeast spliceosome, 
we often use the RP51A, UBC4, or ACT1 pre-mRNAs, all of which splice well in 
vitro.  The pre-mRNA is prepared by transcription with T7 RNA polymerase using 
a PCR-generated template (see Note 1).  The pre-mRNA can be capped during 
transcription by addition of cap analog dinucleotide or after transcription using an 
enzymatic capping system. The transcript may also be trace-labeled with 
radioactive -[32P]-UTP.  This facilitates accurate quantification of the pre-mRNA 
and eliminates the need for exposing the RNA to potentially damaging UV 
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radiation (Greenfeld et al., 2011).  The levels of radiation used are miniscule and 
often undetectable with a Geiger counter in a single molecule assay.  Methods 
for preparation of pre-mRNA substrates by transcription have been published 
elsewhere (Crawford et al., 2008, 2013; Moore and Query, 2000). 
For the “handle” that will be ligated to the 3' end of transcript, we use a 
commercially prepared 27-nucleotide oligonucleotide containing ribose 2'-O-
methyl modifications to prevent degradation and triggering of RNaseH cleavage 
during the splicing assay.  The biotin is incorporated during synthesis at the 3' 
end, and the oligo includes a 5-(2-aminoallyl)uridine to facilitate labeling with N-
hydroxysuccinimide (NHS) activated fluorophores.  These oligos can be 
purchased from a number of commercial suppliers such as IDT or 
Dharmacon/Thermo Scientific.  Conditions for labeling the oligo with fluorophores 
and purification of the labeled oligo have been previously described (Crawford et 
al., 2008). 
The fluorescent handle oligo is 5' phosphorylated using polynucleotide 
kinase (PNK) and joined to the pre-mRNA via splinted ligation with RNA ligase.  
Either T4 RNA Ligase 1 or 2 (RNL1 or 2) can be used, though we often use 
RNL1 and a protocol developed by Stark et al. for this particular junction (Stark et 
al., 2006).  Since RNL1 is a single-stranded ligase, the splint is designed such 
that the 3' and 5' ends of the RNA and biotin handle, respectively, are free but in 
close proximity (Figure2.2).  If RNL2 is used, then the splint is designed to 
directly abut the two ends being joined (Figure 2.2).  Protocols for using RNL1 
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and RNL2 are similar and may need to be optimized for each junction by 
adjusting the ligation time, temperature, amount of enzyme, or ratios of the RNA 
fragments and splint oligo. 
  
            38 
CHAPTER 2. SINGLE MOLECULE SPLICING ASSAYS 
  
 
Figure 2.2  Schemes for splinted ligation to prepare fluorescent, biotinylated pre-
mRNAs. The bold P and OH indicate the 5' phosphate 3' hydroxyl groups of the 
donor biotin handle and acceptor pre-mRNA, respectively.  Sequences shown 
are for the RP51A pre-mRNA substrate.  The biotin handle contains 2' O-methyl 
residues (lowercase m), a fluorophore (star) attached to a 5-aminoallyl-uridine (5-
N-U), and a 3' biotin (Bio).  The DNA splints are continuous, but here represented 
as two distinct portions separated by lines.  (A) Splint and junction design for 
ligation with RNA ligase 2 (RNL2), a double stranded RNA ligase.  (B) Splicing 
and junction design for ligation with RNA ligase 1 (RNL1), a single stranded RNA 
ligase.  Figure adapted from reference (Stark et al., 2006). 
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2.2.1.1 Ligation of a fluorescent biotin handle to a pre-mRNA 
1.  [32P]-labeled pre-mRNA transcript, gel purified (1 
equivalent, 28 pmol in ≤ 8 µL of H2O) 
2. Fluorescent biotin “handle” oligonucleotide (2 equivalents, 
56 pmol in ≤ 3 µL of H2O) 
3.  DNA splint oligonucleotide (1.5 equivalents, 39 pmol in ≤ 
2 µL of H2O) 
4.  T4 Polynucleotide Kinase and 10x PNK Buffer  
5. ATP (700 µM and 20 mM stocks in H2O, each prepared 
fresh from an aliquot of a 100 mM stock solution at pH ~7) 
6. RNasin Plus RNase Inhibitor (optional) 
7. T4 RNA Ligase 1 (RNL1) and 10x RNL1 Buffer  
8. RNase free deionized H2O, not DEPC treated 
9. 1x TBE:  8.9 mM Tris-base, 8.9 mM boric acid, 2 mM 
EDTA 
10. Denaturing polyacrylamide gel:  6%, acrylamide:bis 19:1, 
8M urea, 1x TBE, dimensions ~20x26 cm with ~0.8 mm thick 
spacers 
11. Gel loading buffer:  90% deionized formamide, 1 mM 
EDTA, 0.03% w/v bromophenol blue, 0.03% w/v xylene 
cyanol 
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12. Dye free gel loading buffer: 90% deionized formamide, 1 
mM EDTA 
13. Gel elution buffer:  300 mM sodium acetate pH 5.2, 1 
mM EDTA, 10% v/v phenol pH 4.3 
14. 100% Ethanol, ice cold 
15. 70% v/v Ethanol with RNase free H2O, ice cold  
  16. PCR machine and RNase-free PCR tubes 
  17. Vertical gel apparatus and high voltage power supply 
  18. Scintillation counter, vials, and scintillation fluid 
19. X-ray film and developer or phosphorimager screen and 
scanner 
  20. Whatman filter paper 
 
2.2.2 Generation of Yeast Extracts Containing Tagged Proteins  
CoSMoS splicing experiments often require that spliceosome proteins be 
fluorescently labeled.  This represents a considerable challenge, particularly if 
the experiments are to be conducted in a WCE.  While it is possible to add 
recombinant proteins back to a WCE, many spliceosome proteins are difficult to 
work with and these experiments could necessitate prior depletion of the 
endogenous protein to avoid competition between the native and fluorescent 
molecules.  As an alternative approach, chemical tools can be combined with 
yeast genetics to modify spliceosome proteins with N- or C-terminal protein tags 
            41 
CHAPTER 2. SINGLE MOLECULE SPLICING ASSAYS 
  
in vivo by homologous recombination (Burke et al., 2005).  Small molecule 
fluorophores can then be added to a WCE containing the tagged proteins to 
obtain fluorescent spliceosome components.    
Tagging endogenous proteins by homologous recombination offers 
several advantages.  First, if the yeast strains employed are haploid and proteins 
essential for viability are tagged, then survival of the yeast strains is a good 
indicator that the tagged proteins are functional in vivo.  The effect of the tag on 
yeast growth can also be monitored and compared to the parental strain, as can 
the in vitro splicing activity of the WCE.  Often, but not always, we have found 
that strains which grow poorly also produce WCE with poor splicing activity.  
Another advantage of tagging endogenous proteins is that it eliminates 
complicated procedures involving expression, purification, and labeling of 
recombinant proteins.  The specific activity of the recombinant protein may be 
difficult to determine, and high concentrations are often needed to restore 
splicing activity in depleted extracts.  These concentrations may exceed the limit 
imposed by the TIRF measurement (<100 nM fluorophore in solution).   
The limit on solution fluorophore concentration also impacts which 
proteins can be tagged in the WCE by homologous recombination and 
subsequently visualized by CoSMoS.  We have found that many spliceosome 
proteins are likely present in concentrations of <10 nM in a WCE and many can 
easily be tagged and visualized by CoSMoS.  Other proteins (such as those 
involved in translation) are present at much higher concentrations and these 
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fluorophore labeled proteins could increase the background in the experiment to 
the point that the surface can no longer be discerned.  The yeast GFP database 
(Huh et al., 2003) is an excellent resource for determining the suitability of a 
protein target for tagging and subsequent CoSMoS experiments.  If a highly 
abundant WCE protein is being studied, there are several single molecule 
technologies that can make these experiments possible (Leslie et al., 2010; 
Loveland et al., 2012; Uemura et al., 2010). 
While there is a plethora of protein labeling technologies available, 
aspects of both in vitro splicing and the CoSMoS experiment itself place 
constraints on the applicable methods.  Since proteins will be labeled in WCE, 
labeling must be highly specific for the protein of interest.  If proteins are present 
at low levels in the WCE, the labeling method must be sufficiently rapid to ensure 
a high degree of protein derivatization (ideally quantitative) under conditions that 
will retain the splicing activity of the extract (~30 min at room temperature or ~3h 
at 4oC).  Finally, CoSMoS experiments are greatly facilitated by the bright and 
stable fluorescence signals observed from organic fluorophores.  Many 
fluorescent proteins either photobleach too rapidly for studies of splicing lasting 
tens of minutes, are too dim to observe easily as single molecules, or display 
unfavorable photophysical properties (i.e., blinking) that can confound analysis.    
With these constraints in mind, we empirically determined that two 
component systems relying on a protein tag and small molecule ligand were the 
best suited for labeling spliceosome proteins in WCE.  In our laboratories, we 
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have often used either the E. coli dihydrofolate reductase (EcDHFR) tag 
developed by the Cornish laboratory (marketed by Active Motif) (Miller et al., 
2005), the SNAP or CLIP tags developed by Johnsson and coworkers (marketed 
by New England Biolabs) (Keppler et al., 2002), or the Halo tag developed and 
marketed by Promega (Ohana et al., 2009).  For the purposes of this chapter, we 
will focus on the SNAP tag.   
SNAP tag labeling utilizes a modified human DNA repair enzyme (O6-
alkylguanyl-S-transferase) that becomes alkylated at an active site thiolate in the 
presence of O6-benzylguanine (bG) derivatives (Figure 2.3).  We have found that 
for the SNAP tag protein and most bG fluorophores efficient labeling occurs with 
2 µM bG fluorophore in 30 min at 20oC in WCE.  However, this rate can vary for 
different dye substrates and needs to be determined experimentally for each 
dye/tag pair.  Recently a variant SNAP tag with improved reaction kinetics has 
been reported (“fast SNAP” or SNAPf) (Sun et al., 2011).  With the SNAPf tag, 
efficient labeling can often be achieved with 500 nM dye in ~15 min at 20oC.  In 
addition to the SNAP tag, the CLIP tag has also been developed along with its 
“fast CLIP” counterpart, CLIPf  (Gautier et al., 2008). Rather then being reactive 
towards bG derivatives, the CLIP tags react with benzylcytosine (bC).  We have 
used the CLIP tags successfully for labeling spliceosome proteins albeit with 
slower kinetics and higher substrate requirements than for the SNAP tags.   
A variety of fluorophore bG derivatives are available from New England 
Biolabs or can be synthesized easily from bG-amine building blocks.  In practice, 
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we have found that unpredictable interactions of the fluorophores with the yeast 
extract, stickiness of the fluorophore to glass surfaces used during microscopy, 
or unwanted photophysical properties (e.g., blinking) have limited the choice of 
fluorophores that can be practically used in a CoSMoS experiment.  In general, 
the bG derivatives of Atto-488, DY549, and DY647 (sold as SNAP-Surface ® 
488, 549, and 647, respectively, by New England Biolabs) work well in WCE and 
for CoSMoS experiments.   
During SNAP labeling in WCE, the bG fluorophore is in excess over the 
spliceosome protein being labeled.  The free dye must then be removed prior to 
the CoSMoS experiment.  We have concluded that dialysis is completely 
ineffective for dye removal from labeled extracts, therefore size-exclusion 
chromatography (SEC) is used. We developed a SEC method in which efficient 
dye removal was balanced against maintaining splicing activity by minimizing 
extract dilution.  This SEC method is technically a group separation or desalting 
step, with the extract collected in the column void volume while the free dye 
remains in the column.  With practice, this method can reduce free bG 
fluorophore background to <10 nM while maintaining the splicing activity of the 
WCE. 
  
            45 
CHAPTER 2. SINGLE MOLECULE SPLICING ASSAYS 
  
 
Figure 2.3  Reaction scheme for SNAP-tag protein labeling.  The SNAP-tag 
protein reacts with an O6-benzylguanine dye substrate, transferring the 
fluorophore to an active site cysteine. 
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2.2.2.1 Labeling of Spliceosome Proteins with Fluorophores in Whole Cell 
Extract 
1. Yeast whole cell extract (WCE) from a SNAP-tagged strain (1.2 
mL aliquot, see Note 2) 
2. SNAP-tag bG dye substrate (~1mM in DMSO, New England 
Biolabs, see Note 3) 
3. SEC Buffer:  25mM HEPES-KOH pH 7.9, 50mM KCl, 1 mM DTT, 
10% v/v glycerol 
4. Sephadex G-25, 50% slurry in water  
5. Low pressure liquid chromatography (LPLC) column (e.g., 
Kontes Flex Column, 0.7 x 15cm) 
6. LPLC luer-lock fittings (2x 3-way stopcocks, 1x barbed adapters 
for pump tubing) 
7. Peristaltic pump (e.g., Pump P-1, GE Lifesciences) 
8. Liquid N2 and dewar 
2.2.3 Design of Flow Chambers for TIRF Microscopy and Single Molecule 
Experiments 
 Like many other microscopy techniques, the single molecule 
CoSMoS splicing assay is carried out on glass slides.  These assays can be 
conducted on TIRF microscopes employing either a prism-based or objective-
based illumination scheme.  With prism-based illumination, the excitation source 
is directed onto the sample via a prism positioned on top of the glass slide.  
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When an objective-based illumination scheme is employed, the excitation laser is 
directed onto the sample from the bottom of the glass slide.  Due to these 
differences in geometry, different styles of flow chambers must be used for each 
illumination scheme.  The preparation of flow chambers for prism-based TIRF 
microscopy has been described elsewhere (Selvin, 2008; Zhao and Rueda, 
2009).  Here we illustrate how to manufacture simple flow chambers for an 
objective-TIRF microscope. 
 For colocalization experiments, we manufacture flow chambers 
using disposable glass microscope slides.  It is critical that the glass slide closest 
to the objective be of the proper thickness (typically No. 1.5 cover glass which is 
~0.17mm thick) to obtain images of high quality.  For experiments in which FRET 
is also monitored, then the slide should be made from quartz or fused silica to 
eliminate the high background signal due to impurities found in lower grades of 
glass.  Fused silica slides are extremely fragile, expensive, and non-disposable.  
Instructions for the preparation of No. 0 fused silica slides for CoSMoS can be 
found in other resources (Crawford et al., 2013).  Note that these fused silica 
slides are both thinner and possess a different refractive index than No. 1.5 cover 
glass; consequently, adjustments in the TIR angle and microscope optics are 
necessary to obtain high quality images.  Fused silica slides and coverslips can 
be purchased from suppliers such as SPI Supplies.  
 Whether glass or fused silica slides are used in the experiment, the 
slide and coverslip must be scrupulously cleaned before use.  We often employ a 
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sonic water bath for this purpose.  Alternatively, a plasma cleaner can be used if 
one is available (Selvin, 2008). It is important that the cleaned glass is protected 
from airborne dust particles, and in some environments the slides may need to 
be cleaned and assembled under HEPA air filtration such as a PCR workstation 
or in a hood with horizontal laminar flow (AirClean Systems).  As a part of the 
cleaning procedure, the glass is activated for silanization and derivatization with 
amine reactive polyethylene glycol (PEG) reagents.  Adequate passivation of the 
slide with PEG or other molecules is essential for single molecule experiments to 
prevent non-specific binding of biomolecules to the glass surface. In addition, 
biotin can be incorporated onto the slide surface at this stage for biomolecule 
attachment via PEG-biotin conjugates and streptavidin.  While the methods 
described below have been found to facilitate a great number of experiments, 
occasionally passivation protocols must be optimized by varying the surface 
chemistry, addition of BSA or nucleic acids, or altering the PEG molecule length 
in order to obtain sufficient passivation(Alemán et al., 2009; Revyakin et al., 
2012) (28, 29).  Once assembled and passivated, the slides can be stored at 4oC 
for up to one week.  We find that the lowest amount of non-specific binding 
typically occurs on slides < 24 hours old, and the degree of non-specific binding 
increases with slide age.  In some cases the derivatized slides can be washed, 
dried, and stored at -80oC with desiccant for longer periods of time.  These slides 
are often adequate for day-to-day experiments but may possess a higher degree 
of non-specific surface binding compared to freshly prepared slides.    
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For many experiments, flow chambers can be constructed from simply two 
pieces of glass separated by a thin layer of vacuum grease as described below.  
In this configuration, capillary action is used to introduce liquid into each chamber 
and liquids are wicked out using filter paper.  These slides typically have 4 
chambers, each with a volume of ~20 µL.  More complicated flow chambers with 
altered geometries, attachment points for inlet and outlet tubing, or that use 
alternative materials to vacuum grease [e.g., polydimethylsiloxane (PDMS)] can 
also be constructed.  However, we find that the chamber configuration described 
below is often suitable for a wide-range of CoSMoS experiments.   
After the flow chambers and fluorescent RNAs and extracts have been 
prepared, the CoSMoS experiment is ready to be conducted.  The exact protocol 
will depend on the configuration of the microscope and flow chamber as well as 
the nature of the experiment.  In this chapter, we describe only the fundamentals 
of surface attachment of a fluorescent RNA and introduction of the WCE.  It 
should be noted that these experiments often require the addition of an 
enzymatic oxygen scavenging system and triplet state quenchers to extend 
fluorophore lifetime and limit blinking (Aitken et al., 2008; Crawford et al., 2008; 
Rasnik et al., 2006; Swoboda et al., 2012) (see Note 4).   
The image acquisition protocol, microscope controls, and data processing 
routines will vary depending on the software and hardware preferences of each 
laboratory.  While many laboratories utilize custom software to analyze single 
molecule data, several computer programs have recently become available to 
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facilitate this stage of the experiment (Bronson et al., 2009; Dave et al., 2009; 
Greenfeld et al., 2012; McKinney et al., 2006; Milescu et al.).  The nuances of 
interpreting single molecule data have been described in detail in many 
publications and great care must be taken to account for the observation of a 
single molecule event as well as the probability of having seen that particular 
event during the experiment (Neher and Sakmann, 1976; Schnitzer and Block, 
1995). 
2.2.3.1 Preparation of Flow Chambers for Objective TIRF Microscopy 
1. Micro-90 Cleaning Solution (M-9050-12, International Products 
Corp.) 
2. KOH (100 mM solution in MilliQ H2O) 
3. Ethanol (200 proof) 
4. MilliQ H2O 
5. Vectabond (SP-1800, Vector Laboratories) (see Note 5) 
6. Acetone (spectrophotometric grade, 99+%) 
7. Sodium bicarbonate  
8. Vacuum grease (e.g., Dow Corning high vacuum grease) 
9. Compressed nitrogen gas (ultra high purity) 
10. Biotin-PEG (biotin-PEG-SVA MW 5000, Laysan Bio) (see Note 
5) 
11. PEG succinimidyl valerate MW 5000 (MPEG-SVA-5000, 
Laysan Bio) (see Note 5) 
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12. clear nail polish (optional) 
13.  25 x 25mm cover glass (Corning No. 1.0 or 1.5)  
14. 24 x 60mm cover glass (Gold Seal No 1.5, No. 3423) 
15. Plastic disposable luer lock syringes (3-10 mL) 
16. Empty pipette tip boxes with inserts (e.g., TipOne boxes, USA 
Scientific) 
  17. Razor blades or metal slide holders 
  18. Sonic water bath (e.g., VWR Symphony) 
  19. Slide Mailers x 5 (Fisher Scientific) 
  20. Cover glass forceps  
  21. Wafergard GN Gas Filter Gun (Entegris) 
  22. Syringe filters (0.20 µm, regenerated cellulose) 
2.7 Assembling a Single Molecule Splicing Experiment 
1. Biotinylated, fluorescent pre-mRNA  
2. SNAP labeled yeast WCE 
3.  Cleaned and passivated glass slide 
4. Dithiothreitol (DTT, 1 M stock solution, 0.20 µm filtered, aliquoted 
and stored at -20oC) 
5. PEG 8000 (15% w/v solution in MilliQ H2O, 0.20 µm filtered) 
6. Potassium Phosphate (500 mM in MilliQ H2O, pH 7.3, 0.20 µm 
filtered) 
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7. 3,4-dihydroxybenzoic acid (PCA, 50 mM in MilliQ H2O, aliquoted 
and stored at -80oC, the PCA may be recrystallized from hot MilliQ 
H2O to increase solubility) 
8. Protocatechuate 3,4-dioxygenase from Pseudomonas (PCD, 
resuspended to a concentration of 24-48 U/mL in 50 mM Tris base 
pH 8.0, aliquoted and stored at -80oC) 
9. (±)-6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid 
(trolox) 
10. 200x triplet quencher master mix in DMSO (optional):  100 mM 
propyl gallate, 200 mM 4-nitrobenzyl alcohol, 200 mM 
cyclooctatetraene, aliquoted and stored at -80oC 
11. Streptavidin (10 mg/mL aliquots in PBS, stored at -80oC, 
Prozyme, SA10) 
12. Nuclease Free Bovine Serum Albumin (100 mg/mL) 
13. ATP (100 mM, pH 7, aliquoted and stored at -80oC, optional) 
14. MgCl2 (1 M stock solution, 0.20 µm filtered) 
15. RNasin Plus RNase Inhibitor (Promega, optional) 
16. Filter paper (Whatman 1, 90 mm) 
17. Plastic disposable luer lock syringes 
18. Syringe Filters (0.20 µm, regenerated cellulose) 
19. Low adhesion pipette tips and microcentrifuge tubes 
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2.3 Methods 
  
2.3.1 Ligation of a fluorescent biotin handle to a pre-mRNA transcript 
1. In a small PCR tube, combine the fluorescently labeled biotin 
“handle” oligo (56 pmol) with 0.5 µL of 10x PNK buffer, 0.5 µL of 
700 µM ATP, 0.5 µL of T4 PNK (5 U), and RNase Free H2O for a 
final volume of 5 µL. Avoid prolonged exposure of fluorescent 
materials to light. 
2. Incubate in a PCR machine at 37oC for 60 min to phosphorylate 
the biotin “handle”. Heat inactivate PNK by incubation for 20 min at 
65oC.  Spin down the PCR tube to collect liquids in the bottom. 
3. In a separate PCR tube, combine the pre-mRNA transcript (28 
pmol), the DNA splint oligo (39 pmol), the phosphorylated biotin 
“handle” (56 pmol), and RNase Free H2O to a final volume of 14-15 
µL.  
4. Anneal the pre-mRNA and biotin handle to the splint by 
incubating at 65°C for 3 min in a PCR machine followed by a room 
temperature incubation for 5 min. 
5. Add 1 µL RNasin, 2 µL 10 X RNL1 Buffer, 1 µL of 20 mM ATP, 
and 1-2 µL RNL1 (10-20 U) to a final volume of 20 µL. 
6. Incubate at 37°C for 60 min in a PCR machine.   
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7. While the ligation reaction is incubating, pre-run a 6% acrylamide 
denaturing gel for at least 30 min to an operating temperature of 
~50°C.  It is best to run the gel either in a darkened room or inside 
a large cardboard box to protect the ligated fluorescent RNA from 
light. 
8. Once the ligation reaction has been completed, add an 
equivalent volume of dye-free loading buffer (20 µL) to the reaction 
and load onto the pre-run gel.  Include loading buffer containing 
bromophenol blue and xylene cyanol in an adjacent lane in order to 
track the progress of the electrophoresis. 
9. Carry out gel electrophoresis at constant power (35W) for 1.5-2.5 
h, depending on the size of the RNA transcript and the acrylamide 
gel being used. 
10. Dismantle the gel from the electrophoresis apparatus and 
remove one of the glass plates.  Cover the gel and remaining glass 
plate with plastic wrap.  To locate the ligation product, cut small 
shapes (3-4) out of Whatman filter paper and soak each in a 
radioactive solution of similar activity to the trace-labeled RNA.  
Using clear tape, adhere the filter papers to the plastic wrap in an 
asymmetric pattern around the lane that contains the ligation 
product.  Expose the gel to either X-ray film (~1-5 min) or a 
phosphorimager screen (~1-2 min).  From the developed X-ray film 
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or phosphorimage, create a 1:1 replica copy of the gel on paper 
and cut out the locations of the filter paper shapes and the RNA 
ligation product (usually the upper of two RNA bands) (Figure 2.4).  
 
Figure 2.4  Denaturing polyacrylamide gel purification of the pre-mRNA-biotin 
handle following ligation.  The ligation product (upper band) is well separated 
from the unmodified transcript (lower band). The dark polygon on the right 
originated from a radioactive marker used to determine the location of the ligation 
product before it was excised from the gel. (Gel courtesy of Joshua Larson, U. 
Wisconsin-Madison.) 
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11. Using the paper template, excise the ligated pre-mRNA product 
and place into a 1.5 mL microcentrifuge tube.  It is often beneficial 
to cut the RNA band into small pieces (~1 mm2) and to avoid 
including any excess acrylamide. Add 400 µL of gel elution buffer to 
the tube and centrifuge or vortex briefly to immerse the gel slice in 
the buffer. Freeze the gel slice with dry ice (~5-10 min), wrap the 
tube with aluminum foil to protect the RNA from light, and rotate the 
tube end-over-end for ~16h at room temperature. 
13. After incubation, briefly centrifuge the tube to pellet the 
acrylamide gel slices (12,000 rpm,  ~1 min).  Transfer the extracted 
RNA (supernatant) to a new tube and add 1.2 mL ice cold EtOH. 
14. Incubate at -80°C for ≥ 1 h, then centrifuge at 12-14,000 rpm for 
30 min at 4°C.  Remove the supernatant and wash the pellet with 
70% EtOH and centrifuge as before for 5 min. 
15. Remove the supernatant and air-dry the pellet for 5 min at room 
temperature. 
16. Resuspend the pellet in 50 µL nuclease-free water.  Store the 
RNA in ~10 µL aliquots at -80oC.  Protect the RNA from light using 
amber tubes for storage and/or a light proof container.  
17. The pre-mRNA concentration can be determined by scintillation 
counting using a sample of known concentration as the reference 
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(often a sample of the trace-labeled transcript before ligation or an 
aliquot of the transcription reaction used to produce the RNA). 
 
2.3.2 Labeling of SNAP Proteins in WCE 
1. Assemble a low pressure chromatography column with a 
stopcock and attach to a ring stand in a 4°C cold room (Figure 
2.5A).  With the stopcock closed add 3.8 mL of water and mark the 
height of the water on the side of the column as a reference line.  
Add 0.2 mL of additional water and mark a second reference line 
(4.0 mL).  Drain the water from the column. 
2. Add 7-8 mL of a ~50% Sephadex G25 suspension to the column.  
Open the stopcock and allow the column to begin to drain by 
gravity.  Do not let the column run dry and avoid cracks or channels 
in the resin. 
3. Set up and prime a peristaltic pump with SEC buffer, turn off the 
pump, connect the tubing to the inlet at the top of the column, and 
turn the pump back on to maintain a flow rate of ~0.4 mL/min once 
the resin has packed.   
4. Allow the column bed to compact.  If necessary, adjust the bed 
height to a position between the 3.8 and 4 mL reference marks.  
This can be done by using a glass pipet or tuberculin syringe to 
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resuspend the upper portion of the resin bed and adding or 
removing resin as needed. 
5. Equilibrate the column in SEC buffer for at least 2 hr . 
6. Thaw a 1.2 mL aliquot of yeast extract containing SNAP-tagged 
proteins on  ice. 
7. Add SNAP-tag bG fluorophore substrate to a final concentration 
of 1 µM for the SNAPf tag or 2 µM for the SNAP tag.  Mix the 
solution well by inversion.  
8. Incubate in the dark for 30 min at room temperature, mixing 
every 10 min.  After 30 min, place the extract on ice and 
immediately proceed to the column purification. 
9. Stop the peristaltic pump.  Using a glass pipet or tuberculin 
syringe, gently remove the buffer above the column bed, taking 
care not to disturb the resin.  Allow any remaining buffer on top of 
the resin to drain from the column.  Once all of the buffer has 
entered the resin, close the stopcock to prevent the column from 
drying. 
10. Slowly and gently add the labeled yeast extract to the column 
directly on top of the resin bed being careful to disturb it. 
11. Open the stopcock and allow the extract to drain into the resin.  
Use a 10 mL syringe fitted with a 3-way stopcock to apply manual 
pressure to the top of the column to increase the flow rate to ~0.5 
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mL/min (Figure 2.5B).  The resin will pack (shrink) during 
application of the extract.  After ~1 mL of extract has entered the 
resin, begin collecting the column eluate in 1.5 mL microcentrifuge 
tubes (0.4-0.5 mL per fraction). 
12. Once the extract has entirely entered the resin, release the 
pressure, close the stopcock at the base of the column, and 
remove the syringe and column top.  Carefully add SEC buffer on 
top of the resin and continue adding SEC buffer till the column has 
nearly filled (~4-5 mL).  Re-attach the column top and reconnect to 
the peristaltic pump. 
13. Turn the peristatlc pump on to maintain a flow rate of ~0.25 
mL/min.  Continue to fill the microcentrifuge tube from Step 3 until it 
has reached a volume of 0.4-0.5 mL.  This will be fraction #1.  
Continue to collect 4 additional fractions as the extract elutes from 
the column.  Active extract will typically elute in fractions #2 and #3.  
Avoid prolonged exposure of the labeled extract to light. If possible 
elute the extract in a darkened cold room while using a flashlight to 
monitor each fraction.  Keep the fractions on ice. 
14. Fractions containing the splicing extract should be noticeably 
yellow in color.  Aliquot these fractions in 20-50µL portions, freeze 
in liquid N2, and store at -80oC. 
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15.  Assay each fraction for in vitro splicing activity and compare 
with an unlabeled control extract.  Confirm labeling of the SNAP 
protein by SDS-PAGE of each fraction followed by fluorescence 
imaging of the unstained gel (Figure 2.6).  
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Figure 2.5 (preceding page)  SEC apparatus used to remove excess bG dye 
from SNAP-labeled WCE.  (A) During equilibration and elution, the column is 
connected to a peristaltic pump and fractions collected into 1.5 mL microfuge 
tubes (B) During WCE loading, a syringe is used to apply pressure to the column 
to increase the flow rate.  Photography credit Robin Davies. 
 
 
  
Figure 2.6  Results from SNAP labeling of the spliceosomal Prp16 protein in 
yeast WCE with bG-DY549.  (A) Representative SDS-PAGE gel showing SNAP 
labeling of Prp16 in WCE and visualized by in-gel fluorescence.   Lane 1, protein 
ladder; lane 2, unlabeled wild-type yeast extract; lanes 3 and 4, fractions 
obtained by SEC after labeling the Prp16-SNAP extract. (B) The same gel as in 
A after Commassie blue staining. 
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2.3.3 Flow chamber cleaning and assembly 
1.  Place 1-5 large glass coverslips (24 x 60mm) into a clean slide 
mailer and place 1-5 small glass coverslips (25 x 25 mm) into a 
second mailer.  If slides appear dusty, they can be rinsed with 
MilliQ H2O using a squirt bottle beforehand.  Due to the likelihood of 
breaking or dropping a slide during the following steps, it is best to 
clean more slides at this stage than are needed for subsequent 
experiments. 
2.  Fill each slide mailer with a 0.2% v/v Micro-90 solution in MilliQ 
H2O.  Close the mailer and secure the lid with Parafilm.  Float in a 
sonic water bath for 60 min. 
3.  Remove the slide mailers from the sonic water bath and pour 
out the Micro-90 solution.  Fill the mailer several times with MilliQ 
H2O and pour out the water.  Fill the mailer with 100% ethanol, 
close the lid, and secure with Parafilm.  Float in a sonic water bath 
for 60 min. 
4.  Remove the mailers from the sonic water bath and pour out 
ethanol.  Fill the mailer several times with MilliQ H2O and pour out 
the water.  Fill the mailer with 100 mM KOH in MilliQ H2O, close the 
lid, and secure with Parafilm.  Float in a sonic water bath for 30 
min. 
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5.  Remove the mailers from the sonic water bath and pour out the 
KOH solution.  Fill the mailer several times with MilliQ H2O and 
pour out the water.  Fill the mailer with MilliQ H2O, close the lid, and 
secure with Parafilm.  Float in a sonic water bath for 60 min.  At the 
end of sonication, leave the slides submerged in MilliQ H2O.  It is 
best to proceed directly to derivatization once the slides have been 
cleaned. 
6.  Pour out the MilliQ H2O from the mailer.  While wearing clean 
gloves, carefully remove a slide from the mailer with forceps.  
Grasp the slide securely by the edges while avoiding contact with 
the center of the slide and dry with a stream of high-purity N2 from a 
“filter gun” attached to a gas cylinder.  Once the slide is completely 
dry, transfer it to a new, dry slide mailer. Repeat for each large slide 
and smaller coverslip.  Up to 5 dried slides can be derivatized in 
each mailer, but the slides and coverslips should kept be in 
separate containers. 
7.  Mix 300 µL of Vectabond with 30 mL of acetone in a plastic 50 
mL conical vial.  Add the solution to the slide mailer containing the 
larger slides. Incubate for 5 min. 
8. After 5 min, pour the acetone solution back into the 50 mL 
conical vial and immediately fill the mailer containing the larger 
slides with fresh MilliQ H2O.  Empty the mailer and fill again with 
            65 
CHAPTER 2. SINGLE MOLECULE SPLICING ASSAYS 
  
MilliQ H2O.  Repeat the water rinse two more times.  Leave the 
mailer empty after the final rinse. 
9.  Repeat steps 7 and 8 with the mailer containing the smaller 
coverslips.  The same acetone/Vectabond solution can be reused 
for the coverslips. 
10.  While wearing clean gloves, carefully remove a slide from the 
mailer with forceps and dry with a N2 stream as in Step 6.  Once the 
slide is completely dry, place on a slide holder.  We often use either 
two razor blades or a metal slide holder to secure the slide in an 
empty pipette tip box while avoiding contact with either the top or 
bottom of the slide.  (Figure 2.7A, B) The slide and/or holder 
should be gently taped to the empty pipette tip insert rack to 
prevent movement during subsequent steps or during 
transportation.  The slide can be secured to the holder with tape, a 
small amount of vacuum grease, or with clear nail polish.  To 
prevent the PEGylated slides from drying out, a small piece of 
sponge or paper towel soaked in MilliQ H2O can be placed in the 
bottom of the pipette tip box to create a humid environment. 
11. Using a syringe filled with vacuum grease and fitted with a 
200µL plastic pipette tip, draw five grease lanes horizontally across 
the slide to divide the slide into four chambers (Figure 2.2  
Schemes for splinted ligation to prepare fluorescent, biotinylated 
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pre-mRNAs. The bold P and OH indicate the 5' phosphate 3' 
hydroxyl groups of the donor biotin handle and acceptor pre-mRNA, 
respectively.  Sequences shown are for the RP51A pre-mRNA 
substrate.  The biotin handle contains 2' O-methyl residues 
(lowercase m), a fluorophore (star) attached to a 5-aminoallyl-
uridine (5-N-U), and a 3' biotin (Bio).  The DNA splints are 
continuous, but here represented as two distinct portions separated 
by lines.  (A) Splint and junction design for ligation with RNA ligase 
2 (RNL2), a double stranded RNA ligase.  (B) Splicing and junction 
design for ligation with RNA ligase 1 (RNL1), a single stranded 
RNA ligase.  Figure adapted from reference (Stark et al., 2006)) 
12.  While wearing clean gloves, carefully remove a coverslip from 
the mailer with forceps and dry with a N2 stream as in Step 6.  Once 
the coverslip is completely dry, carefully position it above the center 
of the slide and grease lanes made in steps 10 and 11.  Gently 
push the coverslip into the grease to secure it to the slide and to 
seal each chamber. (Figure 2.7B) 
13.  Prepare a fresh solution (10 mL) of 100 mM sodium 
bicarbonate in MilliQ H2O.  Filter the solution through a 0.2 µm 
syringe filter. 
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14.  Briefly centrifuge a 1 mg aliquot of biotin-PEG to spin any 
solids down to the bottom of the tube.  Dissolve the biotin-PEG in 
400 µL of the sodium bicarbonate solution. 
15.  Briefly centrifuge a 40 mg aliquot of PEG to spin any solids 
down to the bottom of the tube.  Dissolve the PEG in 160 µL of the 
biotin-PEG solution.  Briefly (2s) place the solution in a sonic water 
bath to help the PEG dissolve.  Vortex the solution and then briefly 
centrifuge.  Mix the resulting PEG solution thoroughly by aspirating 
up and down several times with a pipette.   
16.  Add the PEG to the side of each chamber.  It should enter the 
chamber by capillary action.  Avoid getting any of the PEG solution 
outside of the chamber.  One 40 mg aliquot of PEG is typically 
enough to derivatize two slides each containing four 20 µL 
chambers.   
17.  Incubate the slide at room temperature for at least 3 hours and 
up to 16 hours.  
18.  After the room temperature incubation, the slide can be stored 
at 4oC for up to one week. 
  
2.3.4 pre-mRNA Immobilization and Addition of WCE to the Flow Cell  
1.  If the derivatized slide has been kept at 4oC, bring the slide to 
room temperature and allow to equilibrate for ~30-60 min.  
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Warming the slide to room temperature greatly facilitates removal 
of the viscous PEG solution in each lane as well as limits the risk of 
condensation appearing on the slide and interfering with imaging. 
2. Prepare 5-10 mL of 2x Wash Buffer (200 mM KPi pH 7.3, 6% 
PEG 8000, 2 mM DTT) and 2.5 mL of a 2x Splicing Assay Buffer 
(200 mM KPi pH 7.3, 6% PEG 8000, 2 mM DTT, 10 mM PCA, 5 
mM MgCl2, 2 mM Trolox).  It may be necessary to briefly immerse 
the 2x Splicing Assay Buffer in a sonic water bath in order to fully 
dissolve the trolox.  Alternatively, trolox may be added from a 200 
mM stock solution in DMSO or methanol.  These stock solutions 
should be stored at -80oC in single-use aliquots. Filter the 2x Wash 
and Splicing Assay Buffers through 0.2 µm syringe filters.   
3. Prepare a stockpile of “filter paper triangles”.  Cut each filter 
paper into 6-8 triangles, producing pizza slice shaped pieces.  Fold 
each triangle two times by first bringing the pointy end (the bottom 
of the pizza slice) up to the top and then folding in half again along 
an axis perpendicular to the first fold.  We often prepare many 
dozens of these folded triangles at once and store them in empty 
pipette tip boxes.   
4. Prepare 2 mL of 1x Wash Buffer using the 2x stock and RNase 
free MilliQ H2O.  Flush each channel on the slide three times with 
100 µL of the 1x Wash Buffer.  The washing can be carried out on 
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the lab bench using a pipette on one end of the channel and using 
a filter paper triangle on the other end to draw the liquid through the 
channel. (Figure 2.7C)  The PEG solution is quite viscous and will 
move slowly through the channel until it has been cleared.   
5.  The next steps can either be done on the laboratory bench, or if 
permitted by the microscope configuration, on the microscope 
stage itself.  If work is being done on the microscope, mount the 
slide to the stage and position the objective appropriately. Extreme 
care should be taken not to allow liquids to come into contact with 
the objective or other sensitive components. 
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Figure 2.7 (preceding page)  Construction of flow chambers for CoSMoS 
experiments.   (A) A glass slide is placed onto a slide holder (or a pair of razor 
blades) and held in place in a pipette tip box with lab tape.  A syringe is then 
used to draw five thin lines of vacuum grease horizontally across the slide to 
create four chambers.  (B) A clean coverslip is gently pressed on top of the 
lanes.  The chamber is completed with the addition of a PEG:PEG-biotin mixture.  
The completed slide is also shown schematically in Figure 2.1A.  (C) To wash or 
add sample to a flow chamber, a pipette is used to dispense fluid to one side of 
the chamber while the liquid is drawn through to the other side with a small piece 
of folded filter paper.  Photography credit Robin Davies. 
 
 
6.  Immediately prior to each experiment, streptavidin is added to a 
slide channel.  For optimal binding of the RNA added subsequently, 
we recommend adding streptavidin to only one channel at a time 
just before conducting an experiment in that channel.  Using low 
adhesion pipette tips and tubes, prepare 50 µL of a 0.2 mg/mL 
streptavidin solution in 1x Wash Buffer.  Add the entire streptavidin 
solution to a channel on the slide and draw the solution through 
using a filter paper triangle.  Let the channel incubate with 
streptavidin for 2 min and then flush with 200 µL of 1x Wash Buffer.  
Proceed immediately to Step 6. 
7.  Working with low adhesion pipette tips and tubes, prepare a 1 
nM stock of the biotinylated, fluorescent pre-mRNA in 1x Wash 
Buffer that also includes 40 U of RNasin and 0.1 mg/mL nuclease-
free BSA.  Store the RNA stock solution on ice.  From this stock 
solution, prepare 50 µL of a 200 pM RNA stock in 1x Wash Buffer. 
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8.  Introduce the entire 200 pM RNA stock solution into the slide 
channel. If this is being done while the slide is mounted on the 
microscope, the accumulation of the RNA on the slide surface can 
be monitored in real-time.  It is imperative that the microscopic field 
of view does not become too saturated with RNA molecules and 
individual molecules are easily resolved and separated from one 
another.  Typically an appropriate surface density is reached in 2-3 
min, although this can vary.  Stop the RNA accumulation on the 
surface by flushing the channel with 100 µL of 1x Wash Buffer. 
9.  Prepare 100 µL of a 1x Splicing Assay Buffer solution by 
combining the 2x Buffer with ATP (if needed), 0.1 U of PCD, and 
RNase Free Water.  Flush the slide chamber with this solution. 
10.  At this stage, the slide is ready for WCE to be added.  We 
typically position the slide appropriately for the experiment and 
optimize laser powers and TIR at this time.  Once the microscope 
has been appropriately configured for the experiment, proceed to 
step 11.   
11.  Prepare 100 µL of a splicing assay mixture by combining the 
2x Buffer with 2mM ATP (if needed), 35-40µL of the labeled WCE, 
0.1 U of PCD, and RNase Free Water.  Introduce the assay mixture 
to the slide channel and begin image acquisition.  With practice, 
this can be done by hand with a deadtime of ~30s.  For studying 
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events that may occur within that deadtime, a syringe and modified 
flowcell can be used to pull samples into the slide channel during 
data acquisition (Crawford et al., 2013; Friedman et al., 2006). 
12.  We typically acquire data for 30-90 min at intervals of 2-10s 
between frames (1s/fr).  The use of timelapse recording is 
beneficial for reducing photobleaching of the fluorophores during 
long experiments and to prevent laser-induced accumulation of 
fluorescent molecules on the slide surface.  
2.4 Notes 
1.  For efficient ligation, the transcripts should possess 
homogenous 3' ends and +1 (or greater) non-templated addition 
productions should be avoided.  This can easily be accomplished 
by using DNA primers containing 2'-methoxy substituents during 
preparation of the transcription template by PCR (Kao et al., 1999).  
Alternatively, homogenous ends can be generated by targeted 
RNaseH cleavage after transcription (Stone et al., 2007).   
2.  We typically prepare yeast WCE using the method of Ansari and 
Schwer (Ansari and Schwer, 1995) with the exception of using a 
ball mill (Retsch) to lyse the yeast cells.  The yeast WCE can be 
aliquoted (1.2 mL) and frozen at -80oC immediately after high-
speed centrifugation at 37,000 rpm and before dialysis with no 
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effect on splicing activity.  For single molecule assays, it is 
extremely beneficial if the splicing activity of the WCE is as high as 
possible with at least 20% of the pre-mRNA being converted to 
mRNA in 30-45 min at room temperature for yeast WCE. 
3. SNAP tag substrates can be resuspended in DMSO, aliquoted, 
and stored at -20oC.  These aliquots retain labeling activity for many 
months.  It is critical that the concentration of the BG substrate be 
quantified accurately by UV-Visible spectroscopy so that neither too 
much nor too little is added to the yeast WCE during labeling.   
4. Great care must be taken in choosing the appropriate 
combination of oxygen scavengers, reducing agents, and triplet 
quenchers for the single molecule experiment.  These components 
should be tested for possible inhibition or interactions with the 
biomolecules under study including detrimental RNase or DNase 
activity.  Additionally, some oxygen scavenging systems may 
influence the pH of poorly buffered assay mixtures and this should 
be studied prior to setting up the single molecule assay. 
5.  To maintain surface attachment chemistry, both the Vectabond 
and PEG solutions should be carefully aliquoted.  Vectabond can 
be stored in 300 µL aliquots in 1.5 mL microfuge tubes that have 
been backfilled with dry nitrogen or argon.  We store the Vectabond 
at room temperature and protected from light. Aliquots retain 
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activity for several weeks; however, we only aliquot one stock 
solution of Vectabond at a time.  It is critically important that PEG 
and biotin-PEG aliquots be made when the bottles are first opened.  
We typically allow the stock bottles to come to room temperature 
(to avoid condensation) and make ~40 mg aliquots of PEG and ~1 
mg aliquots of biotin-PEG in separate 0.5 mL microfuge tubes.  We 
backfill each tube with dry nitrogen and store at -20oC in a container 
with a tight fitting lid and with desiccant.  These aliquots will retain 
reactivity for many months. 
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3.1 Introduction 
Pre-mRNA splicing is an essential process in eukaryotic gene expression.  
This process is catalyzed by the spliceosome, a large and highly dynamic 
macromolecular machine composed of multiple RNAs and proteins.  The 
spliceosome assembles stepwise on the pre-mRNA substrate as a series of 
complexes defined by their snRNP composition:  A, B, C, P, ILS. 
Spliceosome assembly and disassembly require ATP hydrolysis and are 
modulated by trans-acting factors.  These splicing trans-factors were first 
identified in a yeast genetic screen for splicing deficiencies (Brawerman et al., 
1972).  Nearly all transitions and steps in splicing are governed by DEAH-box 
proteins, a key subset of the SF2 RNA-dependent ATPases.  These proteins 
include Prp2, Prp16, Prp22, and Prp43 and are highly conserved and act at 
sequential steps in the splicing process.  These DEAH-box proteins are thought 
to use their ATPase/helicase activity to remodel the spliceosome at distinct 
stages by disrupting RNA-RNA or RNA-protein interactions. 
One of the most studied DEAH-box family members is Prp22, which acts 
during the second step and promotes release of the spliced mRNA from the 
spliceosome.  Its function during the second step is ATP-independent and 
requires the ordered binding of the proteins Slu7 and Prp18 to the spliceosome 
(James et al., 2002).  Based on data from crosslinking and RNase H protection 
assays, Beate Schwer has proposed a model in which Prp22p facilitates mRNA 
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release by binding downstream of the 3’-exon after exon ligation (Schwer, 2008).  
Prp22p then presumably uses its ATPase activity to disrupt RNA-RNA and RNA-
protein interactions between the mRNA and U5 snRNP components (U5 snRNA 
and Prp8), although how it does this and what exact interactions it disrupts are 
not clear. 
  There remain several open questions concerning these DEAH-box 
proteins and their roles as in splicing and proofreading.  Previous in vitro 
depletion and reconstitution assays have shown at what major transition steps 
they are required.  Yet little is known about when and where they are binding with 
the spliceosome.  The kinetic details of the transient interactions of the DEAH-
box proteins with the spliceosome have not been observed, let alone analyzed.  
In particular, it is not known how their remodeling actions are timed or specified 
to their associated splicing events.  It is also not clear what are their actual RNA 
landing sites and what are the substrates for their remodeling activity.  Finally, 
the nature of the discard step for suboptimal substrates has not been fully 
addressed.  Discard could entail repeated cycles of rejection and testing of 
substrates, or involve a spliceosome disassembly pathway in coordination with 
Prp43 (Mayas et al., 2010). 
The Moore laboratory has recently developed CoSMoS for monitoring the 
comings and goings of individual spliceosomal subcomplexes on surfaced 
tethered pre-mRNA molecules in crude cell lysates.  Previous analyses have 
revealed that every major step in spliceosome assembly is reversible and that 
  78 
CHAPTER 3. THE DYNAMICS OF PRP22 DURING SPLICING 
catalytically active spliceosomes can be assembled by multiple pathways 
(Hoskins et al., 2011; Shcherbakova et al., 2013).  Here I describe the application 
of CoSMoS to follow the dynamics of Prp22 association with spliceosomes 
formed on pre-mRNA molecules capable of completing both steps of splicing.  
The experiments detailed in this chapter demonstrate my ability to watch Prp22 
interact with spliceosomes during splicing.  Analysis of these experiments 
revealed an apparent binding stoichiometry of 1 Prp22 protein per spliceosome, 
and the binding order of Prp22p relative to the NTC (activation) and intron 
release (splicing). 
3.2 Results 
3.2.1 Preparation of fluorescently labeled Prp22 for CoSMoS experiments  
To initiate our Prp22 studies, I used homologous recombination to create 
a haploid yeast strain (Jones, 1977) in which all Prp22 molecules carried a 
fSNAP tag on their C-termini via a (GSG)2 linker (Sun et al., 2011) (Figure 3.1A).  
This tag was introduced into both a strain containing no other tags and a strain 
carrying C-terminal ecDHFR tags tethered to the Cef1 and Ntc90 components of 
the NTC complex(Hoskins et al., 2011).  Consistent with previous studies 
showing that GFP and TAP tags are allowable on Prp22 (Ghaemmaghami et al., 
2003; Huh et al., 2003), our tagged strains grew with the same rates as to their 
respective parental strains (doubling time ~1.4 hr).  However, whole cell extracts 
from the Prp22-fSNAP strains exhibited a defect in step two splicing kinetics in 
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ensemble splicing reactions relative to the respective parental strains (Figure 
3.1B).  This defect was characterized by an excess in lariat intermediate and up 
to ~2 fold less splicing activity compared to the parental strain.  This second step 
defect was also observed by an mRNA displacement assay (Schwer and Gross, 
1998) (Figure 3.1C) wherein the lariat intermediate was observed in both the 
heavy (cosedimented with the spliceosome) and light fractions (released from the 
spliceosome) from the glycerol gradient ultracentrifugation.   
While this second step kinetic defect is significant, the overall splicing 
activity was within the range observed for strains used in previous CoSMoS 
splicing experiments (Anderson and Hoskins, 2014; Hoskins et al., 2011).  
Therefore it didn’t preclude using Pr22-fSNAP for preliminary CoSMoS 
experiments in that the yeast strain grows without issue and still retains an ability, 
albeit lessened, to splice pre-mRNAs and displace spliced mRNA from the 
spliceosome in vitro.  Indeed, using CoSMoS it may be possible to identify and 
distinguish the on and off splicing pathways associated with this strain.  Finally, 
splicing activity as determined by an in vitro splicing assay is highly dependent 
upon the concentration of the whole cell extract being used.  Recent splicing 
assays using labeled Prp22-fSNAP extracts that are up to 4-fold more 
concentrated than extracts typically used for CoSMoS experiments (~80 vs 20 
mg/mL protein concentration by Bradford assay) show qualitatively a much 
higher activity (25-40% splicing vs 15%) and faster splicing kinetics (Figure 
3.1D). 
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To generate labeled extracts for single molecule studies, I used the Snap-
tag dye substrates benzyl-guanosine-DY549 (BG-DY549; green) or BG-CF633 
(red) to label Prp22-fSNAP.  Because S. cerevisae splicing extracts presumably 
lose activity over time, I had to determine optimal labeling conditions that had 
enough dye to achieve near quantitative labeling within 30 minutes at 25°C, but 
not so much that I could not remove it later.  A titration revealed that 1.2uM or 
750 nM BG-DY549 or BG-CF633 was sufficient to saturate labeling of the regular 
or fast versions of Snap-tag within 15 min (Figure 3.1E).  As detailed in section 
2.3, this dye concentration was readily reduced to that usable for CoSMoS 
experiments (i.e., <50 nM) using size exclusion chromatography.   
 
 
 
Figure 3.1 (below):  Preparation of labeled whole cell yeast extracts to be used 
in CoSMoS splicing experiments.  A  Scheme detailing preparation of labeled 
yeast extracts starting with protein engineering in yeast to lysis and labeling of 
the strain.  The size exclusion column is critical for removing the excess dye from 
the labeling reaction.  B  In vitro splicing assay comparing activity of a wild-type 
to a Prp22-Snap extracts; the Prp22 strain splices but less so.  C   Assay for 
mRNA release from the spliceosome using glycerol gradient ultracentrifugation.  
D  In vitro splicing assay of concentrated Prp22-fSnap extracts (~60-80 mg/mL).  
E  SDS-PAGE of a Prp22-fSnap labeling titration to determine the minimal 
amount of Snap-tag dye to be used for saturated labeling in 15 min. 
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3.2.2 Prp22 binding dynamics and stoichiometry 
Ensemble studies have shown that Prp22 only stably associates with late 
stage spliceosomes.  To observe both Prp22p binding dynamics and 
stoichiometry, I ran a 3-color experiment in which blue-labeled RNA locations 
were monitored for colocalization of green and red Prp22 events (Figure 3.2A).  
For these experiments I used an extract wherein individual Prp22 molecules 
carried either a green or a red dye.  To account for non-specific binding a dark 
control was performed.  The dark control is from the same experiment and 
consists of using a similar number of locations that do not have blue RNA spots 
(Friedman and Gelles, 2015).  Both pre-mRNA and Prp22 spots were detected 
using a spot fitting algorithm that finds and centers spots within an image after 
background reduction (Blair and Dufresne; Crocker and Grier, 1996).  A 
colocalized event was defined as a green or red spot of a specified brightness 
landing within 1.5 pixels of the center of the pre-mRNA location.  Fluorescent 
traces were constructed by mapping and drift-correcting pre-mRNA locations 
from the blue field to the green and red Prp22 fields and integrating over the 
course of the experiment (up to ~60 min).  Note, due to poor low signal/noise with 
this particular experiment, both integrated intensities and spot detection were 
performed with averaging every 5 frames.  As a built-in control, ‘dark’ locations 
devoid of a pre-mRNA spot were also integrated and spots detected for Prp22 
signal.  Example traces for different pre-mRNA locations are shown in Figure 
3.2B.   
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To facilitate visual analysis of these data, I prepared rastergrams.  
Rastergrams are a visual tool in which individual traces are reduced to digital 
signals represented as colored bars.  Each row represents a different RNA 
location within the experiment and are stacked onto one another. Rastergrams 
as a visual tool were originally conceived by Phil Zamore and have been used to 
visualize CoSMoS experiments of spliceosome assembly and RNAi (Salomon et 
al., 2015; Shcherbakova et al., 2013) (Figure 3.2C).   
The rastergrams of my 3-color Prp22 experiment show the dynamics of 
Prp22 landings, with multiple comings and goings, consisting of both long and 
short events (Figure 3.2D).  The white space of the rastergrams show the 
absence of detected Prp22 binding activity, with a majority of pre-mRNA 
locations not having any activity at all.  Note this is typical of CoSMoS splicing 
experiments and a feature of the low activity of in vitro splicing assays in general.  
If I compare RNA locations to dark locations (Figure 3.2E), there are about twice 
the number of total events at RNA locations (253 vs 101 events >5 sec).  Thus, 
like the snRNPs, Prp22 association appears to be specific to pre-mRNA locations 
and its association is dynamic with multiple comings and goings. 
Figure 3.2 (below):  Only 1 Prp22 protein binds to the spliceosome at a time.  A  
Scheme for using CoSMoS to determine Prp22 binding stoichiometry; Prp22 has 
been separately labeled with red and green dyes.  B  Example 2-color traces 
showing distinct Prp22 proteins bind close in but not at the same time.  C  A trace 
can be flattened into a 2D digital image and constructed into a rastergram; only 
the binding events are used and depicted with their respective colors.  D-E  
Rastergrams for the RNA and Dark control experiments; red or green bars show 
single Prp22 binding events, blue bars show overlaps, white area is abesence of  
detected events.  
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Previous analysis of snRNP and NTC binding revealed no simultaneous 
binding events for any single species (i.e., subunit stoichiometries = 1;) (Hoskins 
et al., 2011).  This is also most likely true for Prp22.  By encoding different 
species with different colors, rastergrams allow one to easily visualize the 
kinetics of appearance and disappearance of multiple colored species on many 
different RNAs at once (Figure 3.2D). Although I cannot be certain that every 
Prp22 molecule carried a dye in that experiment, I only saw 7 instances of a brief 
overlap (total dwell time ~ 18 min) out of 253 total green and red Prp22 events 
(total dwell time ~ 295 min).  For the dark control data set, there only 5 brief 
overlaps (total dwell time ~4 min) out of 101 total green and red Prp22 events 
(total dwell time ~ 75 min).  Note that the frequency of simultaneous green and 
red Prp22 binding is about the same for the RNA and dark control data sets 
(~0.05%).  Given this I conclude the Prp22 overlaps present in the RNA 
experiment can be ascribed to random background events.  Interestingly, while 
not overlapping, the red and green Prp22 events are often within <10 sec, 
indicating distinct Prp22 molecules binding within short order of one another. 
Thus my data are consistent with Prp22 acting as a monomer, for which there is 
only a single binding site on the spliceosome. 
3.2.3 Prp22 relative to spliceosome activation 
Previous ensemble studies have indicated that Prp22 stably associates 
with post-activation spliceosomes (i.e., C-complex) (Fabrizio et al., 2009; Lardelli 
et al., 2010).  But exactly when Prp22 first associates is not known.  All of these 
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complexes contain the NTC, the acquisition of which is the last major step in 
spliceosome assembly.  Along with displacement of the U1 and U4 snRNPs and 
Brr2-mediated annealing of U2 and U6 snRNAs, stable NTC association is a 
hallmark with activating the spliceosome for first step chemistry.  While 
previously little was known about the NTC structure and where it resides within 
the spliceosome, there have been some interactions (both proteomic and 
genetic) between the NTC and Prp22.  Quite recently a high resolution cryo-EM 
structure of the S. pombe post-activation spliceosome (most likely a mixture of C, 
P and ILS-complexes) has been reported which includes a NTC structure (Yan et 
al., 2015).  The NTC structure occupies a central space above the U5 snRNP 
and catalytic center of the spliceosome, providing a massive extended framework 
of ~ 200 Å2 and 170Å thick.  These structural features suggest perhaps NTC acts 
as a recruiting platform for Prp22 and other splicing factors. 
To determine when Prp22 binds relative to the NTC, I performed 3-color 
CoSMoS experiments with blue-labeled wild type RP51A pre-mRNAs, green-
labeled Prp22 and red-labeled NTC (Figure 3.3A) in the presence or absence of 
ATP.  Extracts depleted of ATP serve as a negative control for splicing and 
spliceosome activation which require the addition of ATP (Liao et al., 1992; Tatei 
et al., 1989).  After recording the RNA locations, the Prp22 and NTC labeled 
WCE was added to the slide chamber and Prp22 and NTC events were recorded 
simultaneously and continuously at a frame rate of 1 frame/sec.  To visually 
analyze these experiments I prepared rastergrams as shown in Figure 3.3B.   
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The rastergrams for 240 RNA locations, 240 dark locations and 287 No ATP 
locations are shown in Figures 3.3C-E.  NTC signals lasting more than 5 
secs/frames were detected at 86 of the RNA+ATP locations (36%), but only 20 of 
the dark locations (8%) and 20 of the RNA No ATP locations (7%).  Similarly, 
Prp22 signals lasting more than 5 secs/frames were detected at 78 of the RNA 
locations (32%), but only 19 of the dark locations (8%) and 60 of the RNA No 
ATP locations (20%).  Finally, 56 RNA locations (23%) exhibited simultaneous 
occupancy of both NTC and Prp22, compared to only 3 dark locations (1%) and 
4 RNA No ATP locations (1%). The relatively high number of Prp22 events in the 
No ATP control experiment is surprising.  However, these events appear to be 
short and could represent a high background from that experiment.  This 
illustrates the background and potential variability associated with CoSMoS 
experiments.  Nonetheless, in general both NTC and Prp22 exhibited many more 
binding events at RNA locations in an ATP dependent manner, with a majority of 
RNAs that bound NTC also binding Prp22.  
Figure 3.3 (below)  Prp22 dynamic binding to the spliceosome is RNA and ATP 
dependent.  A  3-color CoSMoS experiment for watching Prp22 (green) and NTC 
(red) land at pre-mRNA locations (blue).  B  Example raw intensity traces of 
Prp22 and NTC binding to a pre-mRNA.  The gallery of spots (above) shows the 
appearance of Prp22 spots (top row) and later simultaneous disappearance with 
NTC spots (bottom row).  The middle plot shows the same traces but using the 
spot brightness information from the automated spot picker (Blair and Dufresne).  
The dashed line shows if the binding event was colocalized to the RNA location, 
which is where the colored bars of a rastergram depict.  C-E  Unsorted 
rastergrams of the RNA, Dark control and No ATP control Prp22/NTC 
experiments.  NTC, Prp22 and both binding are depicted by red, green and blue 
bars, respectively.     
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While the 3-color rastergrams are informative in that they show the 
entirety of a CoSMoS experiment, it is difficult to directly compare the relative 
timing of the different events.  Andrew Franck has made improvements to the 
rastergrams by adding the abilities to remove empty RNA locations devoid of 
events, sort and align the 3-color rastergrams.  Recently I added a so-called 
wiggle plot option, which displays the total number of events over time.   
To examine the time of appearance for Prp22 versus NTC, I aligned and 
sorted the rastergrams by duration of the first Prp22 event.  This rastergram still 
conveys the whole experiment, but more readily shows the amount of binding 
activity.  For the RP51A +ATP experiment the rastergram shows only about a 
third of the RNA locations have Prp22 and NTC activity (Figure 3.4A).  This is 
greater than the apparent activity of the dark control data, which is <10% (Figure 
3.4B).  Interestingly, the No ATP rastergram again shows little NTC activity, but 
about 20% RNAs have green Prp22 events (Figure 3.4C).  However, 
examination of the corresponding wiggle plot shows the majority of these green 
Prp22 events are relatively short lived (<2 min) compared to the +ATP 
experiment (<10 min).  It appears the No ATP experiment had a significant green 
Prp22 background, however, this was not correlated with NTC activity (i.e., only 4 
RNAs with Prp22/NTC overlaps). 
Figures 3.4D-F show the same rastergrams as before but with empty RNA 
locations removed.  From these rastergrams I made the following observations:  
(1) For the RP51A +ATP experiment, of the 78 RNAs that got a Prp22 signal, 61 
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(78%) also had a NTC signal.  However, of the 60 No ATP RNA and 19 dark 
locations that had a Prp22 signal, only 6 (32%) and 4 (7%) also had a NTC 
signal.  Thus there is a much higher correlation between Prp22 and NTC 
occupancy on pre-mRNAs than at dark or No ATP RNA locations.  (2) Of the 61 
+ATP RNA molecules having both Prp22 and NTC signals, 56 exhibited one or 
more periods of simultaneous occupancy.  (3) For these cases where there was 
an overlap in NTC and Prp22 binding, there was a strong tendency of NTC to 
appear first, followed by a mean delay time of <5 minutes until Prp22 appears 
(estimated from the wiggle plot, Figure 3.4D).  Thus my data strongly suggest 
that stable association of Prp22 with spliceosomes requires prior arrival of the 
NTC.  
 
Figure 3.4 (below)  NTC binding appearance tends to precede Prp22 
appearance.  A  Rastergram and wiggle plots aligned by the first Prp22 event 
and sorted by its duration.  The colored bars are as before (red=NTC, 
green=Prp22, blue=both), grey space indicates no data areas.  From this 
rastergram can estimate the amount of Prp22 activity.  The wiggle plot is simply a 
sum of the Prp22 and NTC events plotted over the experiment time.  B-C  
Rastergrams sorted and aligned as in A, but for the Dark locations and No ATP 
control experiments.  D-F  Same rastergrams as in A-C but with the ‘empty’ 
RNAs devoid of Prp22 events removed.   (The rastergram code was developed 
and kindly shared by Andrew Franck.  Idea of using wiggle plots to sum up the 
rastergrams is from Danny Crawford.)  
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I also ordered the rastergrams by the time of the last Prp22 event (Figures 
3.5A-F).  For the +ATP RNA rastergram, this shows some NTC events extend 
past the last Prp22 event but also some NTC events disappear simultaneously 
with those of Prp22  (Figure 3.5D).  Analysis of the underlying data revealed that 
of the 56 RNAs with Prp22 and NTC overlaps, the Prp22 signal disappears either 
prior to (33 times, 59%) or coincident with (22 times, 39%), but only rarely (1 
time, 2%) after NTC disappearance. I also observed half of the 63 overlaps 
consisted of 1 Prp22 event per NTC event (49%).  The remaining half consisted 
of instances of 2 (22%), 3 (11%), 4 (10%) and more than 5 (9%) Prp22 events 
overlapping with 1 NTC event.  These data suggest that activated spliceosomes 
can bind and release Prp22 multiple times prior to NTC departure.  Once NTC 
disappeared, the Prp22 signal rarely reappeared (3 times) unless the NTC also 
reappeared (8 times). Finally, of the 22 times the Prp22 signal disappeared 
simultaneously with that of the NTC, the majority (17) did not have any 
subsequent binding events of either Prp22 or the NTC. 
 
Figure 3.5 (below)  Ordering of disappearance of Prp22 and NTC events.  A-C  
Rastergrams and wiggle plots for the RNA, Dark locations, and No ATP control 
experiments were aligned by the last Prp22 event and sorted by its duration.  The 
colored bars are as before (red=NTC, green=Prp22, blue=both), grey space 
indicates no data areas.  D-F  Same rastergrams as in A-C but with the ‘empty’ 
RNAs devoid of Prp22 events removed.  
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While the visual patterns of Prp22p and NTC events by rastergrams are 
striking, to gain further insight into the ordering kinetics, I quantified the difference 
in appearance and disappearance times for Prp22p and NTC (tPrp22-tNTC).  I 
restricted this analysis to overlapping events of Prp22 and NTC (i.e., 
simultaneous binding of the pre-mRNA by Prp22 and NTC) and calculated the 
difference in start and end times for such events (Figure 3.6A).  As shown in a 
histogram of the differences in appearance times (Figure 3.6B), the majority 
were positive (90%).  This suggests a binding order of NTC first, followed by 
Prp22, confirming the visual trend observed in the rastergrams.  Note that the 
delay in appearance of Prp22 after NTC binding was ~2 min, which is consistent 
with previous CoSMoS-FRET study of pre-mRNA splicing dynamics (Crawford et 
al., 2013).  An ordering of the NTC followed by Prp22 does not disprove the NTC 
acting as a recruiting element for Prp22 per se and suggests Prp22 interacts with 
spliceosomes after activation (Fabrizio et al., 2009).  Given the lack of 
simultaneous appearance (tPrp22-tNTC = 0, 4%), a pre-formed Prp22-NTC 
complex binding to the pre-mRNA is unlikely. 
I also examined the order of event disappearance for Prp22 and NTC 
overlaps and found most of the differences were negative (62%) (Figure 
3.6C,D).  This would seemingly suggest Prp22 tends to dissociate prior to the 
NTC.  Yet a significant fraction (27%) of the Prp22-NTC overlaps resulted in a 
simultaneous disappearance of both Prp22 and NTC signals (tPrp22-tNTC = 0).  
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This would be representative of the pre-mRNAs that bound both Prp22 and NTC 
which later dissociated at the same time. 
A potential issue with this overlap difference analysis is if one of the two 
events tends to have longer dwell times, then by chance alone I would expect the 
longer event to appear first.  In the case of these experiments, NTC tends to 
have longer dwell times than Prp22 (mean dwell times of ~ 3 vs 1 min 
respectively), so the null hypothesis is the ordering of NTC before Prp22 could be 
due to chance.  To test this I scrambled the experiment such that the Prp22 and 
NTC events were drawn from different RNA locations. Overlaps from this 
scrambled data set were detected and quantified as before.  This scrambling 
procedure was repeated until the scrambled set had a similar or greater number 
of overlaps (n~100) as the original experiment.  As expected, the overlap 
analysis for the scrambled control shows NTC tends to precede Prp22, but not to 
the same extent as the experimental data (Figure 3.6B, red histogram).  Note 
the scrambling control has a larger number of negative arrival events (36%) 
versus the experiment (6%).  I conclude that Prp22 tends to arrive after NTC and 
does not appear as a pre-formed complex (i.e., simultaneous appearance). 
The simultaneous disappearance I observed for Prp22 and NTC is more 
striking in light of the scrambling control.  Here the scrambled data set shows 3% 
simultaneous events versus the 27% for the experiment (Figure 3.6D, red 
histogram).  Note that a disappearance in fluorescent signal can be from a 
dissociation or photobleaching event.  I did not perform a photobleaching control 
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and therefore cannot estimate the contribution of photobleaching to signal 
disappearance.  However, the acquisition conditions of this experiment are 
similar to previous studies with known minimal photobleaching (Hoskins et al., 
2011; Shcherbakova et al., 2013).  Furthermore, the simultaneous 
photobleaching of 3 unique fluorophores on 2 different proteins (1 on Prp22 and 
2 on the NTC) is extremely unlikely and can effectively be ruled out.  Altogether, 
this strengthens my observation that a subset of pre-mRNAs that have Prp22 
and NTC bound at the same time show simultaneous departure of Prp22 and 
NTC.  It is tantalizing to speculate this observation could be ascribed to either 
splicing (i.e., mRNA release from spliceosome) or proofreading (dissociation of 
the spliceosome after unsuccessful splicing). 
 
Figure 3.6 (below)  Determining the difference in appearance and 
disappearance times for Prp22 and NTC overlapping events.  A  Detailed trace of 
overlapped Prp22 and NTC binding at the same RNA location.  The difference in 
appearance times is marked with the solid and dashed black lines.  In this 
example, Prp22 appears well after NTC, so the difference (tPrp22 – tNTC) is 
positive.  B  Histogram of the delays in Prp22 and NTC appearance times.  Note 
this analysis is restricted to only overlapping Prp22 and NTC events (i.e., Prp22 
and NTC bound to the RNA at the same time).  And of those overlaps, only the 
outer pair of events are used for the calculation (i.e., first and last Prp22 event).  
The open red histogram is from a scrambled control of the same data.  The 
scrambling means different Prp22/NTC overlaps are generated by switching RNA 
locations.  C  Same traces as in A but now showing how difference in Prp22 and 
NTC disappearance times are determined.  In this example, Prp22 and NTC 
disappear simultaneously, so the difference is 0.  D  Histogram of the difference 
in Prp22 and disappearance times.  Open red histogram is from scrambled 
control.  
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For these Prp22-NTC overlap events I also examined the wait and dwell 
times of Prp22 (Figure 3.7A).  The wait time of the first Prp22 event is simply the 
time after the start of a NTC event before Prp22 first appeared.   The first Prp22 
event occurs on average ~3 minutes after the start of the NTC event (Figure 
3.7B), which is similar to what the rastergrams and overlap analysis show. In the 
case of multiple Prp22 binding events, the last event mean wait time of 33 
seconds is much shorter (Figure 3.7C).  The longer initial wait time for Prp22 
appearance after NTC binding upstream is consistent with a delay presumably 
due to upstream spliceosome remodeling and splicing events.     
I also examined the mean dwell times for Prp22 events overlapping with 
NTC.  The mean dwell time for all Prp22 events in overlaps of NTC is 74 sec 
(Figure 3.7D).  The dwell times for first or last Prp22 events did not differ with 
means of 70 and 77 sec, respectively (Figure 3.7E and 3.7F).  Without 
knowledge of the photobleaching rate, it is difficult to ascribe meaning to the 
similar dwell times.  Assuming photobleaching is not a significant factor, the 
similar dwell times would suggest the off rate of Prp22 is similar regardless of 
when it binds relative to NTC. 
Figure 3.7 (below)  Detailed examination of the wait and dwell times of Prp22 
binding to the spliceosome.  A  Scheme showing which Prp22 wait and dwell 
times were analyzed; these are only from Prp22/NTC overlapping events.  B  
Histogram of wait times for the first Prp22 binding event after NTC binding.  C  
Histogram of the wait times for the last Prp22 binding events; this is only for 
when there are multiple Prp22 events per 1 NTC event.  D-F  Histograms of the 
dwell times of all, first or last Prp22 events, respectively.     
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3.2.4 Prp22 and NTC binding relative to intron release 
Once exon ligation has occurred, Prp22 uses its ATPase activity to 
dissociate the lariat intron-containing spliceosome from the spliced exons.  
Immediately prior to this event, Prp22 is bound to both the splicing machinery 
(presumably via its N-terminal domain; (Schneider and Schwer, 2001)) and the 
exonic region 15-20 nts downstream of the exon-exon junction (Schwer, 2008).  
Whether Prp22 first releases the spliceosome, first releases the spliced exons, 
releases both stochastically or releases both simultaneously is not known.  It is 
also unknown how many Prp22 binding and release events are required to bring 
about dissolution of the association between the spliceosome and spliced mRNA.  
Finally it is not clear what happens in the event of incorrect splicing – does Prp22 
also promote release from the spliceosome of intermediates that have not 
completed the second step of splicing?   
To address these questions, I next performed a three-color experiment 
using green-labeled Prp22, red-labeled NTC and RPS30A pre-mRNA containing 
7-12 blue (Alexa488) dyes within the intron (Figure 3.8A).  Note this RNA was 
designed and prepared similarly to that used to good effect by Inna 
Shcherbakova (Shcherbakova et al., 2013).  The second step defect associated 
with tagging Prp22 leads to slower second step kinetics (measured ensemble) 
but there is still some splicing activity.  At the single molecule level then it should 
be possible to observe both on and off pathway trajectories for Prp22, NTC and 
the labeled intron (Figure 3.8B).  
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I first assessed the RPS30A pre-mRNAs for specificity and activity of 
Prp22 and NTC binding.  In this manner, the RPS30A pre-mRNA with a labeled 
intron reports only its location and not intron release.  This is similar to the 
RP51A pre-mRNA substrate used in the above experiments.  Figure 3.9A-D 
show the unsorted rastergrams and wiggle plots for 600 RNA locations and 600 
dark locations, both with and without ATP.  In general, the results are similar to 
those for the RP51A experiments, in that the binding of Prp22 and NTC are 
dynamic, RNA-specific and ATP-dependent.  In roughly comparing the peak 
heights of the wiggle plots, it appears all of the control experiments have about 
half the Prp22 and NTC events as the +ATP, +RPS30A pre-mRNA experiment.  
There does seem to be a nonspecific background for both the green Prp22 and 
red NTC signals in the control experiments, but seems to be mostly comprised of 
short-lived events. 
 
Figure 3.9 (below)  Binding of Prp22 to RPS30A containing pre-mRNA 
spliceosomes is RNA specific and ATP dependent.  A-D  Wiggle plots and 
unsorted rastergrams for Prp22 and NTC binding to RPS30A RNA and dark 
locations, both with an without ATP.    
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To examine the activity of the labeled RPS30A pre-mRNA, I aligned the 
rastergram of the RNA locations with ATP by the time to the first NTC event and 
normalized to the active fraction of RNA (i.e., number of RNAs that bound NTC) 
(Figure 3.10A).  I compared this to the same type of rastergram for the RP51A 
experiment described above (Figures 3.10B).  While both RPS30A and RP51A 
had about the same active fraction (~0.3), the binding of NTC to RPS30A was 
faster than RP51A.  Note this observation is similar to the previous findings in 
which RPS30A had faster splicing kinetics than RP51A (Shcherbakova et al., 
2013).  Further note this comparison between activities and kinetics of RPS30A 
and RP51A is confounded by the different whole-cell yeast extracts used in the 
experiments.  While the extracts are from the same tagged Prp22/NTC yeast 
strain, they differ greatly in protein concentration: ~20 vs ~80 mg/mL for the 
RP51A and RPS30A experiments, respectively.  This concentration difference is 
from an improvement in the extract preparation (i.e., reduction in the 
resuspension volume of the yeast pellet prior to lysis) and most likely accounts 
for some of the difference in splicing kinetics between RPS30A and RP51A. 
I next examined the binding order of Prp22 and NTC to the RPS30A pre-
mRNA.  Figure 3.10C shows the rastergram of the RNA locations with ATP 
sorted and aligned by the first Prp22 event.  In general and similar to the trend 
observed with RP51A, Prp22 tends to appear after NTC, but with less of a delay 
as seen with RP51A (~1 vs 2-3 min, compare to Figure 3.4A).  When sorted and 
aligned by the last Prp22 event, the rastergram (Figure 3.10D) showed a general 
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order of disappearance of Prp22 followed by NTC and many simultaneous 
disappearance events of Prp22 and NTC, again similar to the results with RP51A 
(compare to Figure 3.4D).  
 
Figure 3.10 (below)  Prp22 and NTC exhibit similar binding patterns for RP51A 
and RPS30A pre-mRNAs.  A  Wiggle plot and rastergram sorted for time to first 
NTC event in the RPS30A experiment.  The rastergram has been normalized to 
the number of ‘active’ RNAs (i.e., RNAs that bound NTC, ~30%) and x-axis 
scaled past the actual experiment time to facilitate comparison with the RP51A 
rastergram.  B  Wiggle plot and rastergram sorted for time to first NTC event in 
the RP51A experiment.  This rastergram was also normalized to the number of 
active RNA (~30%).  C-D  Wiggle plots and rastergrams for the RPS30A 
experiment sorted and aligned by first and last Prp22 events, respectively.  
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In this experiment splicing or more specifically intron release is defined as 
loss of the fluorescent intron signal.  To examine intron loss due to 
photobleaching a ‘No ATP’ control experiment was performed in which the 
extract was depleted of ATP as before by adding glucose to the WCE.  To 
account for RNA degradation, RNA spots were quantified at the beginning and 
end of the experiment in fields that were exposed to the lasers used in the 
experiment or not.  The difference in the fraction remaining RNA spots in the 
‘+ATP’ and ‘No ATP’ experiments would be due to splicing and photobleaching.  
In this case photobleaching is the dominant process for intron signal loss in that 
there is no difference between the ‘+ATP’ and ‘No ATP’ experiments (Figure 
3.11A).  Even restricting analysis by selecting for brighter initial RNA spots (i.e., 
theoretically more fluorophores) did not show a difference between the ‘+ATP’ 
and ‘No ATP’ experiments.  This suggests that the labeled intron does not 
contain as many fluorophores as determined from UV/Vis quantification of the 
labeled pre-mRNA. 
Despite the apparent failure of the labeled intron to faithfully report on 
splicing, I examined individual RNAs that did have a Prp22, NTC and intron 
signal.  Note this is an advantage of single molecule experiments:  even though 
the experiment failed at the ensemble level, can still look at individual molecules 
to provide some insight.)  My analysis suggests some of the RPS30A pre-
mRNAs with an intron signal still present when Prp22 and NTC colocalize do not 
splice (i.e., intron spots still remain after simultaneous disappearance of 
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Prp22/NTC) (Figure 3.11B).  This result was counter to the expectation of 
simultaneous Prp22/NTC disappearance due to successful splicing.  
Interestingly, after loss of Prp22 and NTC, I do not observe subsequent binding 
events, possibly suggesting these subset of pre-mRNAs are no longer competent 
for spliceosome assembly and splicing.  In some cases, RNA degradation can be 
ruled out since the intron signal remained observable at the surface for several 
minutes after Prp22/NTC disappearance. 
In the other case of intron signal loss during a Prp22/NTC overlap (Figure 
3.11B, right), since loss of fluorescence is only a single step I cannot distinguish 
between photobleaching and intron dissociation. Since the time resolution for the 
intron is poor (acquired 1 sec/frame every 2 min) relative to that of Prp22 and 
NTC (acquired continuously at 1 sec/frame), I also cannot remark on the exact 
timing of intron signal loss relative to the simultaneous disappearance of Prp22 
and NTC.  However, it does hint at what possible splicing would look like under 
these imaging conditions.  
 
Figure 3.11 (below)  Assessing the fate of the RPS30A intron.  A  Intron spot 
survival curves for the RPS30A experiments.  For each plot, the fraction of 
remaining intron spots over time is plotted for the +ATP and No ATP 
experiments.  These plots are progressively filtered for increasing initial spot 
brightness (0 to 5000 pixels).  B  Scheme for possible discard or splicing events 
after Prp22 and NTC binding.  Below are 2 example traces showing spot 
brightness over time for the RPS30A labeled intron, Prp22 and NTC.  Note in 
both cases the simultaneous disappearance of Prp22 and NTC.  
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3.3 Discussion 
The CoSMoS technique has been previously used to study pre-mRNA 
splicing and spliceosome assembly pathways using a combination of 
fluorescently labeled pre-mRNAs and proteins in snRNPs and NTC complexes 
(Crawford et al., 2013; Hoskins et al., 2011; Shcherbakova et al., 2013).  This 
work expands the CoSMoS technique for studying individual proteins involved in 
splicing while retaining the advantages of using multiple labeled complexes and 
pre-mRNA.  This chapter reports on a series of CoSMoS experiments that 
observed the dynamics of the DEAH-box protein Prp22 relative to spliceosome 
assembly and pre-mRNA splicing events.  These experiments used 3 colors to 
directly watch Prp22 interact with spliceosomes during splicing and specifically 
determine its binding stoichiometry, and binding order relative to the NTC and to 
intron release from a surface-tethered pre-mRNA.  Unexpectedly, my results 
suggest that our current model of the ordering of spliced exon release and 
spliceosome disassembly is incomplete.  Although additional experiments are 
required, my data indicate that both Prp22 and the NTC can depart prior to the 
intron product.  I propose alternate disassembly pathways that should be tested 
in the future.  
3.3.1 Preparation of fluorescently labeled Prp22 for CoSMoS experiments  
CoSMoS splicing experiments require a combination of fluorescently 
labeled pre-mRNAs and whole-cell extracts.  Fluorescently labeling of specific 
proteins in WCE is a challenge that was solved by using orthogonal tagging 
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methods, specifically Snap-tag and DHFR-tag systems (Calloway et al., 2007; 
Sun et al., 2011).  All of the DEAH-box proteins involved in splicing are essential 
and therefore a rough but absolute benchmark for tagging is yeast cell viability.  
Yeast strains wherein the Prp22 gene is replaced with a Prp22-c-terminal Snap-
tag fusion are viable and grow at the same rates as wild type.  Nonetheless, in 
vitro assays for splicing activity and mRNA release revealed an ~2-fold kinetic 
defect in the second step in splicing compared to wild type extract.  Yet there 
both splicing and mRNA release do occur in vitro, and the wild type-like growth 
rate of the tagged strain indicates that any kinetic defect is not rate limiting for 
cell growth.  It is also possible this defect could be specific to the model RP51A 
pre-mRNA substrate used in the in vitro splicing assays, but this was not 
examined with other pre-mRNAs.  It is interesting to note that Prp16-fSnap-
tagged extracts show no splicing defect relative to wild type extracts.  This is 
somewhat surprising given extensive sequence and presumably structural 
homology between Prp22 and Prp16.  This could possibly reflect differences in 
accessibility of their binding sites on spliceosome.   
In any event, the second step kinetic effects did not preclude use of 
Prp22-fSnap-tag in CoSMoS experiments since the associated splicing activity 
was within the original variability used for splicing CoSMoS experiments 
(Anderson and Hoskins, 2014; Hoskins et al., 2011).  Indeed, it is possible that 
the tagged strain increases the rate of some off-pathway event, such as a quality 
control decision point.  Thus the tagged strain may have made it possible for use 
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to directly observe both on and off pathways events in one CoSMoS experiment.  
In going forward, however, I would repeat experiments with a longer linker 
between Prp22 and fSnap-tag.  This has been useful in restoring activity of 
difficult proteins (personal communication Aaron Hoskins, Andrew Franck).   
3.3.2 Prp22 binding stoichiometry 
Using a CoSMoS 3-color experiment with dual labeled Prp22 extracts, I 
was able to get a glimpse of Prp22’s binding stoichiometry.  This was previously 
unknown and not readily determined in ensemble experiments.  Proteomics 
experiments require stable complexes, and indeed rely on depletion and/or 
mutant DEAH-box proteins such as Prp22 to accumulate distinct spliceosome 
complexes (Lardelli et al., 2010).  My CoSMoS experiments suggest that only 
one Prp22 protein binds the spliceosome at a time, which hints at the mechanism 
of Prp22-catalyzed mRNA release.  It does not appear to be concerted (i.e., 
multiple Prp22 proteins required), yet multiple binding events of different Prp22 
molecules can occur, sometimes within seconds of each other.   
The approach I used is straightforward in that it only requires labeling of 
the same protein with 2 different colors and looking for the presence or absence 
of overlaps. The caveats of this approach in this case include non-ideal ratios of 
green to red dyes, false-negatives (unlabeled or dark proteins) and possible non-
specific interactions from the dyes used.  In particular, the red dyes used for 
Snap-tag labeling do not typically perform well in CoSMoS experiments due to 
non-specific surface binding and/or high background. Andrew Franck and Joerg 
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Braun have recently employed Snap-tag beads to sponge up excess amounts of 
dye from labeled extracts, which substantially reduces the background due to 
unreacted dye.  This approach should be tried in the future with Prp22-fSnap.  
Nonetheless this was one of the first times such a CoSMoS experiment has been 
tried and highlights the power and simplicity of the approach.  Recently a similar 
approach was used to observe via CoSMoS-FRET the dimer formation of Mcm2-
7, a helicase involved in DNA replication (Ticau et al., 2015).   
3.3.3 Prp22 dynamics relative to NTC (spliceosome activation) 
The NTC is a critical spliceosome component whose stable association 
after tri-snRNP binding and U1 and U4 snRNP release coincides with 
spliceosome activation.  Recent structural work belies the importance of the NTC 
in providing an overall framework for the spliceosome core, and hints at a 
possible role as a docking platform for other splicing proteins (Yan et al., 2015).   
CoSMoS data not only allows direct observation of order-of-assembly 
events, but also can reveal the kinetic details in the timing of these events.  In 
this case, I asked how long after NTC binding does it take for Prp22 to arrive? 
The results in this chapter show that in general Prp22 binds after NTC.  This was 
expected in that Prp22’s action during the second step is known to follow 
spliceosome activation.  That said, Prp22 is a RNA-binding protein and could 
associate with the pre-mRNA and/or one or more snRNAs irrespective of timing 
of splicing events.  Another possibility is Prp22 could interact weakly or short-
lived well before its action is required.  The Lührmann group recently claimed 
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such early interactions for Prp16 and Slu7, but they did not monitor Prp22 (Ohrt 
et al., 2013).  My data indicate these possibilities are unlikely in that the vast 
majority (>90%) of Prp22 events occur after NTC arrival.   
By examining the time difference in overlapped Prp22 and NTC events, I 
could ask how long after NTC binding does it take for Prp22 to arrive?  I observe 
that Prp22 tends to appear within minutes after NTC arrival.  While this is not a 
novel observation per se, it is interesting in that it places Prp22 binding dynamics 
relative to spliceosome assembly events.  Specifically, since we use NTC as a 
reference for spliceosome activation, then clearly Prp22 associates after 
activation.   
Following activation, the spliceosome goes through the chemistry of 
splicing and intron release within a few minutes (Hoskins et al., 2011).  This time 
delay was also observed in CoSMoS-FRET experiments wherein the dynamics 
of the pre-mRNA were timed relative to NTC arrival (Crawford et al., 2013).  In 
that work, pre-mRNA dynamics were measured by FRET between the 5′SS and 
the branch point relative to NTC binding.  This revealed a transition from a low 
FRET state to a toggling between mid and high states after NTC arrival. This 
toggling of FRET states is coincident with spliceosome remodeling events and 
the chemical steps of splicing.  It would be quite interesting to use Danny 
Crawford’s CoSMoS-FRET approach with Prp22 (or Prp16) labeled extracts.  In 
this manner, the Prp22 binding activity I have observed could be timed relative to 
both pre-mRNA conformational dynamics and intron fate. 
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Prp22 has long been known to promote release of spliced mRNA from the 
spliceosome (Company et al., 1991).  Prp22 also presumably uses a similar 
activity to disassemble spliceosomes caught in off-pathway reactions.  Yet the 
mechanism of mRNA release or even what that entails are not well established.  
The Lührmann lab has examined disassembly pathways by proteomics of lariat-
containing spliceosomes that were reconstituted by adding recombinant Prp22 
and Prp43 proteins (Fourmann et al., 2013).  Recently Weijun Chen has 
performed deep sequencing of such complexes in S. pombe, but these studies 
rely on stable complexes remaining after Prp22 action (Chen et al., 2014).  
Possible disassembly models include the orders of dissociation (NTC->Prp22, 
Prp22->NTC, or NTC=Prp22) which are not necessarily mutually exclusive.  My 
data shows evidence for all 3 possibilities, with the majority of events being 
Prp22 disappearance first.  About half of the time, another molecule of Prp22 
rebinds the NTC, indicating that Prp22 is much more dynamic than the larger 
complex.  This high dynamics of Prp22 relative to NTC is consistent with the 
model that Prp22 functions as a proof-reader to help resolve spliceosomes that 
are somehow kinetically stalled in an inactive conformation (Chen et al., 2012; 
Mayas et al., 2010; Semlow and Staley, 2012)  
Another intriguing feature of the Prp22 and NTC ordering is the extent of 
their simultaneous disappearance.  Although it is impossible without proper 
photobleaching controls to definitively distinguish between dissociation and 
photobleaching of a single fluorophore labeled protein, a strong argument can be 
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made about the extreme unlikelihood for simultaneous photobleaching of 3 
different fluorophores labeled on 3 different proteins at the level observed in my 
experiments.  Given that these simultaneous disappearances are most likely real, 
what then do they represent?  It is tantalizing to suggest these events reflect 
successful splicing and dissociation of the mRNA from the spliceosome.  Another 
possibility is an off-pathway reaction proofread by Prp22.  Indeed, given the 
splicing defect of the Prp22-Snap-tagged WCE, there may well be a combination 
of both on- and off-pathway events.   
By parsing analysis of Prp22 binding events into those that occur either in 
the absence of NTC or overlap with NTC binding, I was able to show that long-
lived Prp22 events (~70 sec mean dwell time) only occur in the presence of NTC. 
That Prp22 binding events overlapping the NTC all had the same mean dwell 
time hints at how Prp22 works.  Consistent with the above stoichiometry studies, 
the fluorescence intensity traces indicated that only one Prp22 molecule can bind 
simultaneously.  Yet, sometimes there are multiple rounds of Prp22 binding to 
NTC-containing spliceosomes.  Because all Prp22 dwells overlapping NTC were 
the same regardless of whether they were the first or later binding events, it 
appears that the binding site for Prp22 is created in a single step.  That is, unlike 
the case for NTC binding where there is evidence for an initial weak binding site 
preceding formation of a strong binding site (Hoskins et al., eLife, under review) 
there are no discernible dwell time differences between first, middle or last Prp22 
binding events.  I observed no short lived binding attempts at the beginning of 
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any Prp22-NTC overlaps, meaning that Prp22 binding is not in any way initially 
restricted.   
Although I observed no differences in dwell times, there was a difference 
in wait times.  When multiple Prp22 binding events occurred per NTC event, the 
mean wait time for the last Prp22 event was much shorter than the first (33 vs 
179 seconds).  Following activation (i.e., binding of NTC), Prp22 binds within 
minutes and is thought to follow the remodeling activity of Prp16 during the 
transition from the 1st to second step in which the proteins Cwc25 and Yju2 are 
displaced (Tseng et al., 2011).  Perhaps Cwc25 and Yju2 occlude the binding 
site(s) of the second step factors Prp22, Slu7 and Prp18.  This would also be 
consistent with the 2-state model of spliceosome dynamics in which the 
spliceosome is in equilibrium between 2 conformational states that favor either 
the first or second step of splicing (Konarska et al., 2006).  Perhaps the longer 
initial wait time for Prp22 is a result of the spliceosome being driven from 
activation to a first step conformation.  It would be interesting to repeat these 
Prp22 experiments with extracts also containing Prp16 (favors the first step 
conformation) or with Prp8 mutant suppressors that favor one step or the other 
(Abelson, 2013; Liu et al., 2007). 
In kinetic proofreading, there have been 2 models as to how the 
proofreader works: as a timer or a sensor (Semlow and Staley, 2012).  These 
models are not necessarily mutually exclusive, but evaluation of these models 
has not been possible using ensemble methods.  This is a case where directly 
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watching the dynamics and therefore having access to the underlying kinetics is 
a huge advantage to single molecule methods (Qian, 2008).  My observation of 
no significant differences in the wait or dwell times for Prp22 binding to the 
spliceosome is more consistent with Prp22 acting as a timer than a sensor.  
Convincing demonstration of this, however, awaits additional experimental data 
wherein more events can be analyzed.   It will also be quite interesting to repeat 
these Prp22 experiments using a mixture of wild type (with labeled intron) and 
3′SS mutant pre-mRNAs on the same surface in an extract in which the NTC or 
Prp43 (necessary for spliceosome disassembly) is also labeled. 
 
3.3.4 Prp22 and NTC departure relative to intron release (splicing) 
I also attempted to frame these Prp22 and NTC events in the context of 
splicing by performing a 3-color CoSMoS experiment using the RPS30A pre-
mRNA with a labeled intron.  Although the number of pre-mRNA molecules for 
which I could confidently distinguish intron departure from photobleaching was 
too small to yield reliable statistics, it was intriguing to examine the intron fate for 
this small subset (see below).  That both spliceosome assembly and splicing 
occurred on this labeled pre-mRNA was confirmed by the ATP dependence of 
Prp22 and NTC binding (spliceosome assembly/activation) and intron 
disappearance (splicing and intron departure).   This rules out nuclease activity 
as a primary reason for intron disappearance, since labeled pre-mRNA 
molecules were present throughout the experiment for Prp22 and NTC to interact 
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with.  The data also confirmed that Prp22 and NTC ordering and binding 
behaviors on RPS30A pre-mRNA are in general similar to what I observed with 
RP51A pre-mRNA. 
After careful analysis individual traces, I identified 15 pre-mRNA 
molecules for which disappearance of the intron signal most likely resulted from 
splicing.  For 3 of these pre-mRNAs, the final Prp22 and NTC departures 
occurred in the interval between the final intron observation and the first time 
point when the intron was no longer visible.  These events most likely represent 
successful splicing and intron departure.  In all 3 cases, Prp22 and NTC 
disappeared simultaneously, consistent with the current model that the upon 
spliced exon release by Prp22, the lariat intron product departs as ILS complex 
containing the NTC and likely also Prp22.  Lack of Prp22 detection in the S. 
pombe ILS (Chen et al., 2014) suggests that Prp22's association with ILS is 
transient.  
The 9 cases where loss of intron signal occurred after final Prp22 and 
NTC departure are intriguing in that they may represent spliceosome discard.  
While it is well established that Prp22 is a proofreader of the second step (Mayas 
et al., 2006), how it achieves this and what the discard pathway entails is 
unknown.  For 3 pre-mRNA molecules wherein the last Prp22 and NTC 
disappearances occurred prior to loss of intron fluorescence, Prp22 and NTC 
disappeared simultaneously.  This suggests that one outcome of a Prp22-
dependent discard pathway is loss of either NTC or the entire spliceosome.  In 
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future experiments it will be interesting to explore in greater detail these splicing 
and discard pathways.  Rather than rely on loss of a labeled intron, perhaps 
direct detection of the spliced mRNA by an exon-junction targeting probe (e.g., 
fluorescently labeled gamma-PNA (Dragulescu-Andrasi et al., 2006)) would be 
more straight-forward. 
 
3.3.5 Perspective 
 In the work described here, I demonstrated that CoSMoS can be used to 
observe the comings and goings and binding stoichiometry of the splicing factor, 
Prp22, on individual pre-mRNA molecules. This extends CoSMoS analysis of 
spliceosome dynamics to protein molecules that bind individually rather than as 
part of a larger complex.  Further I demonstrated that Prp22 binding is dynamic 
and occurs after spliceosome activation (i.e., NTC arrival).  Finally, my data have 
provided a first glimpse into the ordering of a likely Prp22-dependent 
spliceosome discard pathway.  My experiments thus lay the groundwork for 
future researchers to dissect the late stages of spliceosome action, disassembly 
and quality control using single molecule methods. 
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3.4 Materials and Methods 
3.4.1 Preparation of whole cell extracts 
Yeast extracts were prepared from various strains with Prp22-fSnap 
and/or NTC-double-DHFR (Cef1-DHFR, Ntc90-DHFR) as described previously 
(Hoskins et al., 2011) and in section 2.3. 
3.4.2 Preparation of fluorescent pre-mRNAs 
The RP51A pre-mRNA was biotinylated and labeled with a single 
Alexa488 fluorophore as described in section 2.1. 
The RPS30A pre-mRNA with a labeled intron was designed and prepared 
as before (Shcherbakova et al., 2013).  However, a biotin handle oligo was 
ligated to the 3′ end of the pre-mRNA in place of the Klenow extension used in 
the reference. 
3.4.3 Construction of flow chambers 
The microscope slides and flow chambers used in these CoSMoS 
experiments were prepared as described in section 2.5. 
3.4.4 CoSMoS TIRF microscopy 
Splicing reactions and fluorescent Prp22 and NTC images were recorded 
using a multi-wavelength single molecule fluorescence microscope that has been 
described previously (Friedman et al., 2006) and GLIMPSE software 
(https://github.com/gelles-brandeis/Glimpse).  The single molecule splicing 
assays were assembled as described in section 2.7.  The aquistion settings used 
  122 
CHAPTER 3. THE DYNAMICS OF PRP22 DURING SPLICING 
were similar to previous CoSMoS splicing experiments (Hoskins et al., 2011; 
Shcherbakova et al., 2013). 
3.4.5 Analysis of CoSMoS data 
The recorded images from the CoSMoS experiments were analyzed using 
custom Matlab software created and provided by Larry Friedman 
(https://github.com/gelles-brandeis/CoSMoS_Analysis) and has been described 
previously (Friedman and Gelles, 2015). 
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4.1 Development of CoSMoS methods for studying splicing 
The CoSMoS technique was established by Larry Friedman and Jeff 
Gelles nearly 9 years ago and has fundamentally advanced our understanding of 
not only spliceosome assembly and pre-mRNA splicing, but a wide range of 
biological processes.  To achieve this understanding required an incredible 
amount of methods development, troubleshooting and extensive combination of 
various disciplines including yeast genetics, fluorescently labeling of proteins and 
RNA, surface chemistry, TIRF microscopy and image analysis.  This would not 
be possible without the partnership between the Moore and Gelles labs, and 
collaboration with New England Biolabs and Virginia Cornish for orthogonal 
protein labeling technology. 
My thesis research using CoSMoS started with a lab rotation in the Moore 
lab under Aaron Hoskins.  I was tasked with finding a way to specifically label 
proteins in yeast extracts to be later be used in CoSMoS splicing experiments.  
We quickly arrived at using Snap-tag labeling technology as one of the few 
methods that was compatible with extracts and in vitro splicing conditions.  The 
problem however was removal of excess dye from the labeling reaction – even 
with a small excitation volume, the TIRF microscope used for CoSMoS does not 
tolerate high backgrounds.  I recalled during my rotation in the Jacobson lab the 
yeast extracts used in ribosome toeprinting assays were prepared via gel 
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filtration chromatography.  Traditionally splicing extracts are dialyzed, but this 
does not sufficiently remove the free Snap-tag dye.  Using my love of 
chromatography, I was able to develop a size exclusion chromatography method 
that separated the bulk of free dye from the extract.  Critically, this did not 
fractionate the extract or alter the associated splicing activity.  This method of 
dye removal from labeled extracts became instrumental to the further 
development and success of CoSMoS splicing experiments, and is the salient 
feature common to all of the CoSMoS splicing publications to date.  Indeed, 
without the specificity of Snap-tag labeling and the low background afforded from 
the dye removal method, there would not be many spots to see and count during 
a splicing reaction. 
4.1.1 Future development of CoSMoS 
The power of the CoSMoS method for studying the dynamics of 
biomolecules as they come and go lies in its simplicity and versatility.  Interested 
researchers need only have one labeled biomolecule tethered to the slide 
surface, from which they (hopefully) observe the colocalization of another labeled 
biomolecule.  But this versatility is betrayed by the amount work and care 
required for acquisition and analysis of the images.  Both processes have been 
quite labor intensive, and in some aspects there is (or should be) no avoiding it.  
Nonetheless, the software tools employed to acquire and analyze CoSMoS have 
improved significantly in the past few years.  My first CoSMoS experiments 
consisting of <100 RNAs to analyze required over 1 day of computer processing, 
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followed by weeks of manual analysis.  Currently, thanks to improvements made 
by Larry Friedman in the Matlab code employed (Friedman and Gelles, 2015), I 
can process ~500 RNAs in less than a half hour.  Sadly, the subsequent 
analysis, while semi-automated, requires careful manual supervision and still 
takes weeks before I know if the experiment truly worked or not.  This will not 
change until new methods are used for CoSMoS image analysis (Smith et al., 
2010), which Andrew Franck and Carlas Smith are attempting to establish.  If 
successful, these new methods potentially allow the analysis of a CoSMoS 
experiment in near real-time with an accuracy in spot detection currently not 
possible.  Finally, it would be extremely constructive if the community of CoSMoS 
researchers adopted a storage of annotated and standardized data/methods that 
could later be utilized as a resource.  With adaption of electronic notebooks, this 
should no longer be an issue and will help standardize CoSMoS from a boutique 
method.         
4.2 The dynamics of Prp22 during splicing 
After helping develop the CoSMoS toolkit, my thesis research switched to 
applying those tools to the study of trans-acting helicases involved in promoting 
the fidelity and conformational rearrangements associated with splicing.  I was 
quite interested in watching the dynamics of Prp22 during splicing and was 
inspired by the work from Jon Staley’s lab demonstrated Prp22 as a proofreader 
of the second step of splicing (Mayas et al., 2006).  The actual mechanism of 
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Prp22 as proofreader and the nature of the discard step were open questions 
that could be answered by my CoSMoS experiments.  By definition, anything I 
saw would be novel, yet it was not so.  Plagued by variability in yeast extract 
preparations, microscope slide stickiness, TIRF microscope adjustments, etc. I 
could not distinguish between Prp22’s real and dark control events, let alone say 
anything about proofreading.  It wasn’t until I saw the clarity afforded Danny 
Crawford’s CoSMoS-FRET experiments by combining a labeled spliceosomal 
subcomplex that I decided to monitor Prp22 relative to spliceosome assembly 
and splicing itself. 
By using a yeast strain in which Prp22 and the NTC were respectively 
fSnap and DHFR tagged, I could prepare extracts for watching Prp22 and NTC 
binding events during splicing.  I was initially disappointed to merely confirm the 
expected ordering of NTC appearing first, later followed by Prp22.  Moreover, my 
experiments were still plagued by nonspecific dye accumulation on the slide 
surface – sometimes it was the green Snap-tag dye (Prp22), sometimes the red 
DHFR-Cy5-TMP (NTC).  I finally realized I could actually ignore the nonspecific 
background (provided it was not dominating the experiment) and focus on events 
in which Prp22 and NTC coloacalized on the same RNA at the same time.  In 
effect, I was using NTC binding events as a filter for selecting possibly interesting 
Prp22 events. 
To aid in my analysis, Larry Friedman kindly provided me with a matlab 
script that detected such overlaps.  I have added to and refined the script to the 
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point where such overlap analysis for a 3-color CoSMoS experiment is routine.  
Analysis of the Prp22/NTC overlapping events provided a detailed look at Prp22 
dynamics during splicing that have been heretofore unknown.  I find that the 
apparent ordering shows a 2-3 min delay from NTC binding before the first Prp22 
binding event in that overlap.  After that initial Prp22 binding event, the wait times 
decrease to ~1 min.  The longer initial wait time suggests Prp22 is somehow 
restricted from binding to the spliceosome, presumably until after the first step.  
This delay is similar to the one Danny Crawford saw for onset of toggling of a mid 
to high FRET state after NTC arrival (Crawford et al., 2013).  Again, it would be 
tantalizing but not at this time feasible to combine labeled Prp22 extracts with 
Danny’s FRET pre-mRNA to see where Prp22 events would be in the sea of 
FRET dynamics. 
Of especial interest to me is the simultaneous disappearance of Prp22 
and NTC signal.  This occurs fairly frequently (30% of Prp2/NTC overlaps) and 
possibly hints at either a spliced mRNA release or discard step.  I would love to 
follow these experiments up with different extracts in which Prp22 would be 
monitored with other labeled snRNPs (U5 and U2) and observe their possible 
initial disassembly events.   
I tried to follow up this observation by also monitoring the fate of the intron 
using the labeled RPS30A intron.  Inna Shcherbakova first designed and used 
this pre-mRNA to monitor splicing (Shcherbakova et al., 2013).  The long intron 
of RPS30A allows the use of one color to monitor its fate.  Unfortunately in my 
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case the labeling of the intron was not extensive enough to distinguish intron 
release from photobleaching.  Especially disappointing was the lack of difference 
in intron signal lifetime in the +/- ATP experiments.  Yet both Prp22 and NTC 
provided RNA and ATP dependent events, which is evidence the experiment 
itself worked.   Nonetheless it is quite intriguing to see cases in which the intron 
loss signal while Prp22 and NTC were present (possible splicing) and when 
Prp22 and NTC departed simultaneously but the intron clearly remained.   
Going forward I would like to prepare a brighter splicing reporter to be 
used in follow experiments.  I would of course also try reducing the second step 
splicing defect associated with Prp22-fSnap by using a longer linker and/or using 
more concentrated extracts that Andrew Franck and I have been developing.  
Finally, I would also repeat the Prp22/NTC experiments to establish both 
reproducibility and the extent of photobleaching.  As such my current dataset 
serves as a preliminary data that illustrates the possibilities of monitoring a trans-
acting helicase during splicing. 
4.2.1 Future CoSMoS experiments with Prp22 and other splicing ATPases 
The identity of the splicing ATPases are prominently linked with splicing 
fidelity and the theory of kinetic proofreading.  Sean Burgess and Christine 
Guthrie first beautifully demonstrated the ability of Prp16 helicase mutants to 
allow for stabilization of mutant branch point containing lariat intermediates in 
yeast cells (Burgess and Guthrie, 1993).  From these observations came idea of 
the splicing helicases acting as a “proofreading clock”.  Later Beate Schwer 
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demonstrated the ability to immunodeplete Prp16 from yeast extracts, then 
restore its function by adding back recombinant Prp16 (Schwer and Guthrie, 
1991).  This technique has been adopted and used nearly ad nauseam by Jon 
Staley and Soo Chen-Cheng in a series of increasingly convoluted experiments 
to dissect and demonstrate the functional and fidelity roles of Prp16 and other 
DEAH-box proteins (Koodathingal et al., 2010; Tseng et al., 2011).   
From those complicated experiments, David Horowitz has extracted an 
interesting theory or flavor of proofreading in which the helicases don’t act as 
proofreaders per se (Horowitz, 2011).  Rather, and in the case of Prp16, it is the 
protein Cwc25 that performs the fidelity check of the branch point and Prp16 acts 
as an ‘expediter’ moving the splicing reaction forward.  Upon examination of the 
spliceosome assembly and splicing pathway, it becomes apparent this model of 
pairing a sensor protein with an ATPase could be applied to nearly all of the 
transitions these helicases govern (refer to Figure 1.4).  It would be interesting to 
evaluate this model using CoSMoS splicing experiments in which different 
splicing proteins are orthogonally tagged and observed against wild-type and 
mutant pre-mRNAs.  To this end, I already have the different combinations of 
yeast strains prepared (e.g. Prp22/Slu7, Prp16/Cwc25,Prp2/Spp2), which could 
be combined with a labeled intron containing pre-mRNA to watch the comings 
and goings of splicing (Figure 4.1) 
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4.3 Final thoughts 
I would like to close with a quote from Paul de Kruif’s Microbe Hunters 
attributed to Antonie van Leeuwenhoek (de Kruif, 1962): 
People who look for the first time through a microscope say now I 
see this and then I see that – and even a skilled observer can be 
fooled.  On these observations I have spent more time than many 
will believe, but I have done them with joy, and I have taken no 
notice of those who have said why take so much trouble and what 
good is it? – but I do not write for such people but only for the 
philosophical!”  
In his near breathless style of prose, Paul de Kruif paints a picture of 
Leeuwenhoek as a careful experimenter, constantly searching and reevaluating 
what he was seeing, always questioning.  As the father of Microbiology and an 
accomplished microscope builder, Leeuwenhoek saw something novel every 
time he peered into the then unknown microscopic world.  Leeuwenhoek’s 
balancing curiosity and caution in exploring new things is a mindful lesson for 
those today using single molecule microscopy methods I think.  In helping 
establish the tools and methods used for CoSMoS splicing experiments I am 
quite mindful of the need to practice care and restraint in collecting and analyzing 
data.  Yet I have also experienced the allure and amazement of simply counting 
spots and look forward to what those spots can reveal. 
  132 
BIBLIOGRAPHY 
 
Abelson, J. (2008). Is the spliceosome a ribonucleoprotein enzyme? Nat Struct Mol Biol 
15, 1235–1237. 
Abelson, J. (2013). Toggling in the spliceosome. Nat. Struct. Mol. Biol. 20, 645–647. 
Abelson, J., Hadjivassiliou, H., and Guthrie, C. (2010a). Preparation of Fluorescent Pre-
mRNA Substrates for an smFRET Study of Pre-mRNA Splicing in Yeast. In Single 
Molecule Tools: Fluorescence Based Approaches, Part A, (Academic Press), pp. 31–
40. 
Abelson, J., Blanco, M., Ditzler, M.A., Fuller, F., Aravamudhan, P., Wood, M., Villa, T., 
Ryan, D.E., Pleiss, J.A., Maeder, C., et al. (2010b). Conformational dynamics of single 
pre-mRNA molecules during in vitro splicing. Nat Struct Mol Biol 17, 504–512. 
Aitken, C.E., Marshall, R.A., and Puglisi, J.D. (2008). An Oxygen Scavenging System 
for Improvement of Dye Stability in Single-Molecule Fluorescence Experiments. Biophys 
J 94, 1826–1835. 
Alemán, E.A., Pedini, H.S., and Rueda, D. (2009). Covalent-Bond-Based Immobilization 
Approaches for Single-Molecule Fluorescence. ChemBioChem 10, 2862–2866. 
Anderson, E.G., and Hoskins, A.A. (2014). Single Molecule Approaches for Studying 
Spliceosome Assembly and Catalysis. In Spliceosomal Pre-mRNA Splicing, K.J. Hertel, 
ed. (Humana Press), pp. 217–241. 
Anna Marie Pyle (2008). Translocation and Unwinding Mechanisms of RNA and DNA 
Helicases. 
Ansari, A., and Schwer, B. (1995). SLU7 and a novel activity, SSF1, act during the 
PRP16-dependent step of yeast pre-mRNA splicing. EMBO J. 14, 4001–4009. 
Aronova, A., Bacíková, D., Crotti, L.B., Horowitz, D.S., and Schwer, B. (2007). 
Functional interactions between Prp8, Prp18, Slu7, and U5 snRNA during the second 
step of pre-mRNA splicing. RNA 13, 1437–1444. 
Blair, D., and Dufresne, E. Matlab Particle Tracking. 
Blanchard, S.C., Gonzalez, R.L., Kim, H.D., Chu, S., and Puglisi, J.D. (2004). tRNA 
selection and kinetic proofreading in translation. Nat Struct Mol Biol 11, 1008–1014. 
Brody, E., and Abelson, J. (1985). The “spliceosome”: yeast pre-messenger RNA 
associates with a 40S complex in a splicing-dependent reaction. Science 228, 963–967. 
Bronson, J.E., Fei, J., Hofman, J.M., Gonzalez Jr., R.L., and Wiggins, C.H. (2009). 
Learning Rates and States from Biophysical Time Series: A Bayesian Approach to 
Model Selection and Single-Molecule FRET Data. Biophys. J. 97, 3196–3205. 
  133 
BIBLIOGRAPHY 
Brow, D.A. (2002). Allosteric Cascade Of Spliceosome Activation. Annu. Rev. Genet. 
36, 333–360. 
Burge, C.B., Tuschl, T., and Sharp, P.A. (1999). Splicing of precursors to mRNAs by the 
spliceosomes. In The RNA World (Second Edition), R.F. Gesteland, T.R. Cech, and J.F. 
Atkins, eds. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press), pp. 525–
560. 
Burgess, S.M., and Guthrie, C. (1993). A mechanism to enhance mRNA splicing fidelity: 
The RNA-dependent ATPase Prp16 governs usage of a discard pathway for aberrant 
lariat intermediates. Cell 73, 1377–1391. 
Burke, D.J., Amberg, D.C., and Strathern, J.N. (2005). Methods in Yeast Genetics: A 
Cold Spring Harbor Laboratory Course Manual (Cold Spring Harbor, NY: CSHL Press). 
Calloway, N.T., Choob, M., Sanz, A., Sheetz, M.P., Miller, L.W., and Cornish, V.W. 
(2007). Optimized Fluorescent Trimethoprim Derivatives for in vivo Protein Labeling. 
ChemBioChem 8, 767–774. 
Chen, W., and Moore, M.J. (2014). The spliceosome: disorder and dynamics defined. 
Curr. Opin. Struct. Biol. 24, 141–149. 
Chen, H.-C., Tseng, C.-K., Tsai, R.-T., Chung, C.-S., and Cheng, S.-C. (2012). A Link of 
NTR-Mediated Spliceosome Disassembly with DEAH-box ATPases Prp2, Prp16 and 
Prp22. Mol. Cell. Biol. 
Chen, W., Shulha, H.P., Ashar-Patel, A., Yan, J., Green, K.M., Query, C.C., Rhind, N., 
Weng, Z., and Moore, M.J. (2014). Endogenous U2·U5·U6 snRNA complexes in S. 
pombe are intron lariat spliceosomes. RNA. 
Company, M., Arenas, J., and Abelson, J. (1991). Requirement of the RNA helicase-like 
protein PRP22 for release of messenger RNA from spliceosomes. Nature 349, 487–
493. 
Cordin, O., Hahn, D., and Beggs, J.D. (2012). Structure, function and regulation of 
spliceosomal RNA helicases. Curr. Opin. Cell Biol. 1–8. 
Couto, J.R., Tamm, J., Parker, R., and Guthrie, C. (1987). A trans-acting suppressor 
restores splicing of a yeast intron with a branch point mutation. Genes Dev. 1, 445–455. 
Crawford, D.J., Hoskins, A.A., Friedman, L.J., Gelles, J., and Moore, M.J. (2008). 
Visualizing the splicing of single pre-mRNA molecules in whole cell extract. RNA 14, 
170–179. 
Crawford, D.J., Hoskins, A.A., Friedman, L.J., Gelles, J., and Moore, M.J. (2013). 
Single-molecule colocalization FRET evidence that spliceosome activation precedes 
stable approach of 5′ splice site and branch site. Proc. Natl. Acad. Sci. 110, 6783–6788. 
  134 
BIBLIOGRAPHY 
Crocker, J.C., and Grier, D.G. (1996). Methods of Digital Video Microscopy for Colloidal 
Studies. J. Colloid Interface Sci. 179, 298–310. 
Dave, R., Terry, D.S., Munro, J.B., and Blanchard, S.C. (2009). Mitigating Unwanted 
Photophysical Processes for Improved Single-Molecule Fluorescence Imaging. Biophys. 
J. 96, 2371–2381. 
Dulin, D., Lipfert, J., Moolman, M.C., and Dekker, N.H. (2013). Studying genomic 
processes at the single-molecule level: introducing the tools and applications. Nat. Rev. 
Genet. 14, 9–22. 
Fabrizio, P., Dannenberg, J., Dube, P., Kastner, B., Stark, H., Urlaub, H., and 
Lührmann, R. (2009). The Evolutionarily Conserved Core Design of the Catalytic 
Activation Step of the Yeast Spliceosome. Mol. Cell 36, 593–608. 
Fourmann, J.-B., Schmitzová, J., Christian, H., Urlaub, H., Ficner, R., Boon, K.-L., 
Fabrizio, P., and Lührmann, R. (2013). Dissection of the factor requirements for 
spliceosome disassembly and the elucidation of its dissociation products using a 
purified splicing system. Genes Dev. 27, 413–428. 
Friedman, L.J., and Gelles, J. (2012). Mechanism of Transcription Initiation at an 
Activator-Dependent Promoter Defined by Single-Molecule Observation. Cell 148, 679–
689. 
Friedman, L.J., and Gelles, J. (2015). Multi-wavelength single-molecule fluorescence 
analysis of transcription mechanisms. Methods 86, 27–36. 
Friedman, L.J., Chung, J., and Gelles, J. (2006). Viewing Dynamic Assembly of 
Molecular Complexes by Multi-Wavelength Single-Molecule Fluorescence. Biophys. J. 
91, 1023–1031. 
Gautier, A., Alex, Juillerat,  re, Heinis, C., Jr, I.R.C., Kindermann, M., Beaufils, F., and 
Johnsson, K. (2008). An Engineered Protein Tag for Multiprotein Labeling in Living 
Cells. Chem. Biol. 15, 128–136. 
Ghaemmaghami, S., Huh, W.-K., Bower, K., Howson, R.W., Belle, A., Dephoure, N., 
O’Shea, E.K., and Weissman, J.S. (2003). Global analysis of protein expression in 
yeast. Nature 425, 737–741. 
Gilbert, W. (1978). Why genes in pieces? Nature 271, 501–501. 
Greenfeld, M., Solomatin, S.V., and Herschlag, D. (2011). Removal of Covalent 
Heterogeneity Reveals Simple Folding Behavior for P4-P6 RNA. J. Biol. Chem. 286, 
19872–19879. 
Greenfeld, M., Pavlichin, D.S., Mabuchi, H., and Herschlag, D. (2012). Single Molecule 
Analysis Research Tool (SMART): An Integrated Approach for Analyzing Single 
Molecule Data. PLoS ONE 7, e30024. 
  135 
BIBLIOGRAPHY 
Hartwell, L.H. (1967). Macromolecule Synthesis in Temperature-sensitive Mutants of 
Yeast. J. Bacteriol. 93, 1662–1670. 
He, Y., Andersen, G.R., and Nielsen, K.H. (2010). Structural basis for the function of 
DEAH helicases. EMBO Rep 11, 180–186. 
Hopfield, J.J. (1974). Kinetic Proofreading: A New Mechanism for Reducing Errors in 
Biosynthetic Processes Requiring High Specificity. Proc. Natl. Acad. Sci. U. S. A. 71, 
4135–4139. 
Horowitz, D.S. (2011). The splice is right: Guarantors of fidelity in pre-mRNA splicing. 
RNA 17, 551–554. 
Hoskins, A.A., Friedman, L.J., Gallagher, S.S., Crawford, D.J., Anderson, E.G., 
Wombacher, R., Ramirez, N., Cornish, V.W., Gelles, J., and Moore, M.J. (2011). 
Ordered and Dynamic Assembly of Single Spliceosomes. Science 331, 1289–1295. 
Hoskins, A.A., Gelles, J., and Moore, M.J. New insights into the spliceosome by single 
molecule fluorescence microscopy. Curr. Opin. Chem. Biol. 
Huh, W.-K., Falvo, J.V., Gerke, L.C., Carroll, A.S., Howson, R.W., Weissman, J.S., and 
O’Shea, E.K. (2003). Global analysis of protein localization in budding yeast. Nature 
425, 686–691. 
James, S.-A., Turner, W., and Schwer, B. (2002). How Slu7 and Prp18 cooperate in the 
second step of yeast pre-mRNA splicing. RNA 8, 1068–1077. 
Jankowsky, E., and Bowers, H. (2006). Remodeling of ribonucleoprotein complexes 
with DExH/D RNA helicases. Nucl Acids Res 34, 4181–4188. 
Jones, E.W. (1977). PROTEINASE MUTANTS OF SACCHAROMYCES CEREVISIAE. 
Genetics 85, 23–33. 
Joo, C., Fareh, M., and Narry Kim, V. (2013). Bringing single-molecule spectroscopy to 
macromolecular protein complexes. Trends Biochem. Sci. 38, 30–37. 
Jurica, M.S., and Moore, M.J. (2003). Pre-mRNA Splicing: Awash in a Sea of Proteins. 
Mol. Cell 12, 5–14. 
Kao, C., Zheng, M., and Rüdisser, S. (1999). A simple and efficient method to reduce 
nontemplated nucleotide addition at the 3 terminus of RNAs transcribed by T7 RNA 
polymerase. RNA 5, 1268–1272. 
Keppler, A., Gendreizig, S., Gronemeyer, T., Pick, H., Vogel, H., and Johnsson, K. 
(2002). A general method for the covalent labeling of fusion proteins with small 
molecules in vivo. Nat. Biotechnol. 21, 86–89. 
  136 
BIBLIOGRAPHY 
Konarska, M.M., Vilardell, J., and Query, C.C. (2006). Repositioning of the Reaction 
Intermediate within the Catalytic Center of the Spliceosome. Mol. Cell 21, 543–553. 
Koodathingal, P., Novak, T., Piccirilli, J.A., and Staley, J.P. (2010). The DEAH Box 
ATPases Prp16 and Prp43 Cooperate to Proofread 5’ Splice Site Cleavage during Pre-
mRNA Splicing. Mol. Cell 39, 385–395. 
Krishnan, R., Blanco, M.R., Kahlscheuer, M.L., Abelson, J., Guthrie, C., and Walter, 
N.G. (2013). Biased Brownian ratcheting leads to pre-mRNA remodeling and capture 
prior to first-step splicing. Nat. Struct. Mol. Biol. advance online publication. 
de Kruif, P. (1962). Microbe Hunters. 
Lardelli, R.M., Thompson, J.X., Yates, J.R., and Stevens, S.W. (2010). Release of SF3 
from the intron branchpoint activates the first step of pre-mRNA splicing. RNA 16, 516–
528. 
Leslie, S.R., Fields, A.P., and Cohen, A.E. (2010). Convex Lens-Induced Confinement 
for Imaging Single Molecules. Anal. Chem. 82, 6224–6229. 
Liao, X.C., Colot, H.V., Wang, Y., and Rosbash, M. (1992). Requirements for U2 snRNP 
addition to yeast pre-mRNA. Nucleic Acids Res. 20, 4237–4245. 
Lin, R., Newman, A., Cheng, S., and Abelson, J. (1985). Yeast mRNA splicing in vitro. J 
Biol Chem 260, 14780–14792. 
Liu, L., Query, C.C., and Konarska, M.M. (2007). Opposing classes of prp8 alleles 
modulate the transition between the catalytic steps of pre-mRNA splicing. Nat Struct 
Mol Biol 14, 519–526. 
Loveland, A.B., Habuchi, S., Walter, J.C., and van Oijen, A.M. (2012). A general 
approach to break the concentration barrier in single-molecule imaging. Nat. Methods 9, 
987–992. 
Maeder, C., Kutach, A.K., and Guthrie, C. (2009). ATP-dependent unwinding of U4/U6 
snRNAs by the Brr2 helicase requires the C terminus of Prp8. Nat Struct Mol Biol 16, 
42–48. 
Mayas, R.M., Maita, H., and Staley, J.P. (2006). Exon ligation is proofread by the 
DExD/H-box ATPase Prp22p. Nat Struct Mol Biol 13, 482–490. 
Mayas, R.M., Maita, H., Semlow, D.R., and Staley, J.P. (2010). Spliceosome discards 
intermediates via the DEAH box ATPase Prp43p. Proc. Natl. Acad. Sci. 
McKinney, S.A., Joo, C., and Ha, T. (2006). Analysis of Single-Molecule FRET 
Trajectories Using Hidden Markov Modeling. Biophys. J. 91, 1941–1951. 
Milescu, L., Nicolai, C., and Bannen, J. QUB - Software for single-molecule biophysics. 
  137 
BIBLIOGRAPHY 
Miller, L.W., Cai, Y., Sheetz, M.P., and Cornish, V.W. (2005). In vivo protein labeling 
with trimethoprim conjugates: a flexible chemical tag. Nat Meth 2, 255–257. 
Moore, M.J., and Proudfoot, N.J. (2009). Pre-mRNA Processing Reaches Back 
toTranscription and Ahead to Translation. Cell 136, 688–700. 
Moore, M.J., and Query, C.C. (2000). [7] Joining of RNAs by splinted ligation. In RNA - 
Ligand Interactions, Part A, (Academic Press), pp. 109–123. 
Moore, M.J., and Sharp, P.A. (1993). Evidence for two active sites in the spliceosome 
provided by stereochemistry of pre-mRNA splicing. Nature 365, 364–368. 
Neher, E., and Sakmann, B. (1976). Single-channel currents recorded from membrane 
of denervated frog muscle fibres. Nature 260, 799–802. 
Nettels, D., Gopich, I.V., Hoffmann, A., and Schuler, B. (2007). Ultrafast dynamics of 
protein collapse from single-molecule photon statistics. Proc. Natl. Acad. Sci. 104, 
2655–2660. 
Ninio, J. (1975). Kinetic amplification of enzyme discrimination. Biochimie 57, 587–595. 
Ohana, R.F., Encell, L.P., Zhao, K., Simpson, D., Slater, M.R., Urh, M., and Wood, K.V. 
(2009). HaloTag7: A genetically engineered tag that enhances bacterial expression of 
soluble proteins and improves protein purification. Protein Expr. Purif. 68, 110–120. 
Ohrt, T., Odenwälder, P., Dannenberg, J., Prior, M., Warkocki, Z., Schmitzová, J., 
Karaduman, R., Gregor, I., Enderlein, J., Fabrizio, P., et al. (2013). Molecular dissection 
of step 2 catalysis of yeast pre-mRNA splicing investigated in a purified system. RNA 
19, 902–915. 
Pan, Q., Shai, O., Lee, L.J., Frey, B.J., and Blencowe, B.J. (2008). Deep surveying of 
alternative splicing complexity in the human transcriptome by high-throughput 
sequencing. Nat. Genet. 40, 1413–1415. 
Qian, H. (2008). Cooperativity and Specificity in Enzyme Kinetics: A Single-Molecule 
Time-Based Perspective. Biophys. J. 95, 10–17. 
Rasnik, I., McKinney, S.A., and Ha, T. (2006). Nonblinking and long-lasting single-
molecule fluorescence imaging. Nat. Methods 3, 891–893. 
Revyakin, A., Zhang, Z., Coleman, R.A., Li, Y., Inouye, C., Lucas, J.K., Park, S.-R., 
Chu, S., and Tjian, R. (2012). Transcription initiation by human RNA polymerase II 
visualized at single-molecule resolution. Genes Dev. 26, 1691–1702. 
Roy, J., Kim, K., Maddock, J.R., Anthony, J.G., and Woolford, J.L. (1995). The final 
stages of spliceosome maturation require Spp2p that can interact with the DEAH box 
protein Prp2p and promote step 1 of splicing. RNA 1, 375–390. 
  138 
BIBLIOGRAPHY 
Salomon, W.E., Jolly, S.M., Moore, M.J., Zamore, P.D., and Serebrov, V. (2015). 
Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of 
Its Nucleic Acid Guides. Cell 162, 84–95. 
Schneider, S., and Schwer, B. (2001). Functional Domains of the Yeast Splicing Factor 
Prp22p. J Biol Chem 276, 21184–21191. 
Schnitzer, M.J., and Block, S.M. (1995). Statistical kinetics of processive enzymes. Cold 
Spring Harb. Symp. Quant. Biol. 60, 793–802. 
Schwer, B. (2008). A Conformational Rearrangement in the Spliceosome Sets the 
Stage for Prp22-Dependent mRNA Release. Mol. Cell 30, 743–754. 
Schwer, B., and Gross, C.H. (1998). Prp22, a DExH-box RNA helicase, plays two 
distinct roles in yeast pre-mRNA splicing. EMBO J. 17, 2086–2094. 
Schwer, B., and Guthrie, C. (1991). PRP16 is an RNA-dependent ATPase that interacts 
transiently with the spliceosome. Nature 349, 494–499. 
Selvin, P.R. (2008). Single-Molecule Techniques: A Laboratory Manual (Cold Spring 
Harbor, NY: CSHL Press). 
Semlow, D.R., and Staley, J.P. Staying on message: ensuring fidelity in pre-mRNA 
splicing. Trends Biochem. Sci. 
Shcherbakova, I., Hoskins, A.A., Friedman, L.J., Serebrov, V., Corrêa, I.R., Xu, M.-Q., 
Gelles, J., and Moore, M.J. (2013). Alternative Spliceosome Assembly Pathways 
Revealed by Single-Molecule Fluorescence Microscopy. Cell Rep. 5, 151–165. 
Silverman, E., Edwalds-Gilbert, G., and Lin, R.-J. (2003). DExD/H-box proteins and their 
partners: helping RNA helicases unwind. Gene 312, 1–16. 
Smith, C.S., Joseph, N., Rieger, B., and Lidke, K.A. (2010). Fast, single-molecule 
localization that achieves theoretically minimum uncertainty. Nat. Methods 7, 373–375. 
Smith, D.J., Query, C.C., and Konarska, M.M. (2008). “Nought May Endure but 
Mutability”: Spliceosome Dynamics and the Regulation of Splicing. Mol. Cell 30, 657–
666. 
Spingola, M., Grate, L., Haussler, D., and Ares, M. (1999). Genome-wide bioinformatic 
and molecular analysis of introns in Saccharomyces cerevisiae. RNA N. Y. N 5, 221–
234. 
Stark, M.R., Pleiss, J.A., Deras, M., Scaringe, S.A., and Rader, S.D. (2006). An RNA 
ligase-mediated method for the efficient creation of large, synthetic RNAs. RNA 12, 
2014–2019. 
  139 
BIBLIOGRAPHY 
Stone, M.D., Mihalusova, M., O’Connor, C.M., Prathapam, R., Collins, K., and Zhuang, 
X. (2007). Stepwise protein-mediated RNA folding directs assembly of telomerase 
ribonucleoprotein. Nature 446, 458–461. 
Sun, X., Zhang, A., Baker, B., Sun, L., Howard, A., Buswell, J., Maurel, D., Masharina, 
A., Johnsson, K., Noren, C.J., et al. (2011). Development of SNAP-Tag Fluorogenic 
Probes for Wash-Free Fluorescence Imaging. ChemBioChem 12, 2217–2226. 
Swoboda, M., Henig, J., Cheng, H.-M., Brugger, D., Haltrich, D., Plumeré, N., and 
Schlierf, M. (2012). Enzymatic Oxygen Scavenging for Photostability without pH Drop in 
Single-Molecule Experiments. ACS Nano 6, 6364–6369. 
Tatei, K., Kimura, K., and Ohshima, Y. (1989). New methods to investigate ATP 
requirement for pre-mRNA splicing: inhibition by hexokinase/glucose or an ATP-binding 
site blocker. J. Biochem. (Tokyo) 106, 372–375. 
Ticau, S., Friedman, L.J., Ivica, N.A., Gelles, J., and Bell, S.P. (2015). Single-Molecule 
Studies of Origin Licensing Reveal Mechanisms Ensuring Bidirectional Helicase 
Loading. Cell 161, 513–525. 
Tsai, A., Petrov, A., Marshall, R.A., Korlach, J., Uemura, S., and Puglisi, J.D. (2012). 
Heterogeneous pathways and timing of factor departure during translation initiation. 
Nature 487, 390–393. 
Tseng, C.-K., and Cheng, S.-C. (2008). Both Catalytic Steps of Nuclear Pre-mRNA 
Splicing Are Reversible. Science 320, 1782–1784. 
Tseng, C.-K., and Cheng, S.-C. (2013). The spliceosome catalyzes debranching in 
competition with reverse of the first chemical reaction. RNA 19, 971–981. 
Tseng, C.-K., Liu, H.-L., and Cheng, S.-C. (2011). DEAH-box ATPase Prp16 has dual 
roles in remodeling of the spliceosome in catalytic steps. RNA 17, 145–154. 
Uemura, S., Aitken, C.E., Korlach, J., Flusberg, B.A., Turner, S.W., and Puglisi, J.D. 
(2010). Real-time tRNA transit on single translating ribosomes at codon resolution. 
Nature 464, 1012–1017. 
Valadkhan, S. (2010). Role of the snRNAs in spliceosomal active site. RNA Biol. 7, 
345–353. 
Wahl, M.C., Will, C.L., and Luhrmann, R. (2009). The Spliceosome: Design Principles of 
a Dynamic RNP Machine. Cell 136, 701–718. 
Walbott, H., Mouffok, S., Capeyrou, R., Lebaron, S., Humbert, O., van Tilbeurgh, H., 
Henry, Y., and Leulliot, N. (2010). Prp43p contains a processive helicase structural 
architecture with a specific regulatory domain. EMBO J. 29, 2194–2204. 
  140 
BIBLIOGRAPHY 
Wang, Y., and Guthrie, C. (1998). PRP16, a DEAH-box RNA helicase, is recruited to 
the spliceosome primarily via its nonconserved N-terminal domain. RNA 4, 1216–1229. 
Wang, Y., Wagner, J.D.O., and Guthrie, C. (1998). The DEAH-box splicing factor Prp16 
unwinds RNA duplexes in vitro. Curr. Biol. 8, 441–451. 
Warkocki, Z., Odenwalder, P., Schmitzova, J., Platzmann, F., Stark, H., Urlaub, H., 
Ficner, R., Fabrizio, P., and Luhrmann, R. (2009). Reconstitution of both steps of 
Saccharomyces cerevisiae splicing with purified spliceosomal components. Nat Struct 
Mol Biol. 
Weiss, S. (2000). Measuring conformational dynamics of biomolecules by single 
molecule fluorescence spectroscopy. Nat. Struct. Mol. Biol. 7, 724–729. 
Will, C.L., and Lührmann, R. (2011). Spliceosome Structure and Function. Cold Spring 
Harb. Perspect. Biol. 3. 
Wlodaver, A.M., and Staley, J.P. (2014). The DExD/H-box ATPase Prp2p destabilizes 
and proofreads the catalytic RNA core of the spliceosome. RNA. 
Xu, Y.-Z., and Query, C.C. (2007). Competition between the ATPase Prp5 and branch 
region–U2 snRNA pairing modulates the fidelity of spliceosome assembly. Mol. Cell 28, 
838–849. 
Yan, C., Hang, J., Wan, R., Huang, M., Wong, C.C.L., and Shi, Y. (2015). Structure of a 
yeast spliceosome at 3.6-angstrom resolution. Science aac7629. 
Yildiz, A., Forkey, J.N., McKinney, S.A., Ha, T., Goldman, Y.E., and Selvin, P.R. (2003). 
Myosin V Walks Hand-Over-Hand: Single Fluorophore Imaging with 1.5-nm 
Localization. Science 300, 2061–2065. 
Zhao, R., and Rueda, D. (2009). RNA folding dynamics by single-molecule fluorescence 
resonance energy transfer. Methods 49, 112–117. 
Zhuang, X., Bartley, L.E., Babcock, H.P., Russell, R., Ha, T., Herschlag, D., and Chu, S. 
(2000). A Single-Molecule Study of RNA Catalysis and Folding. Science 288, 2048–
2051. 
 
